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Abstract  
BACKGROUND 
Drug courts are specialized courts in which court actors collaboratively use the legal and 
moral authority of the court to monitor drug-involved offenders’ abstinence from drug 
use via frequent drug testing and compliance with individualized drug treatment 
programs. Drug courts have proliferated across the United States in the past 20 years 
and been adopted in countries outside the United States. Drug courts also have expanded 
to non-traditional populations (juvenile and DWI offenders).  
OBJECTIVES 
The objective of this review is to systematically review quasi-experimental and 
experimental (RCT) evaluations of the effectiveness of drug courts in reducing 
recidivism, including drug courts for juvenile and DWI offenders. This systematic review 
critically assesses drug courts’ effects on recidivism in the short- and long-term, the 
methodological soundness of the existing evidence, and the relationship between drug 
court features and effectiveness. 
SEARCH STRATEGY 
We used a multi-pronged search strategy to identify eligible studies. We searched 
bibliographic databases, websites of several research organizations involved in drug 
court research, and the references of eligible evaluations and prior reviews.  
SEARCH CRITERIA 
Evaluations eligible for inclusion in this review were evaluations of drug courts that used 
an experimental and quasi-experimental comparison group design.  Studies must also 
have had an outcome that examined criminal or drug-use behavior (recidivism).  
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DATA COLLECTION AND ANALYSIS 
From each evaluation, we coded an effect size that quantified each court’s effect on 
various measures of recidivism (general recidivism, drug-related recidivism, and drug 
use). We also coded features of the drug court program, research methodology, and 
sample. We analyzed effect sizes using the random-effects inverse-variance weight 
method of meta-analysis. 
MAIN RESULTS 
One hundred fifty-four independent evaluations of drug courts met our eligibility 
criteria; 92 of these assessed adult drug courts, 34 examined juvenile drug courts, and 28 
investigated DWI drug courts. If all of the evaluations are considered, the evidence 
suggests that adult and DWI drug courts reduce general and drug-related recidivism; in 
fact, the mean effect size for both adult and DWI drug courts is analogous to a drop in 
recidivism from 50% for non-participants to approximately 38% for participants.  
Moreover, the effects of adult drug courts appear to persist for at least three years. If only 
the three experimental evaluations of adult drug courts are considered, the evidence still 
supports the effectiveness of adult drug courts, as all three experimental evaluations find 
sizeable reductions in recidivism, although there was inconsistency in the durability of 
the effects over time. Three of the four experimental evaluations of DWI drug courts find 
sizeable reductions in recidivism; however, one experimental evaluation found a 
negative effect. Thus, the evidence is suggestive of effectiveness of DWI drug courts but 
this conclusion is not definitive. For juvenile drug courts we find considerably smaller 
effects on recidivism. The mean effect size for these courts is analogous to a drop in 
recidivism from 50% for non-participants to roughly 43.5% for participants. 
CONCLUSIONS 
These findings support the effectiveness of drug courts in reducing recidivism, but the 
strength of this evidence varies by court type. The evidence finds strong, consistent 
recidivism reductions in evaluations of adult drug courts. DWI drug courts appear to be 
strong but this evidence is less consistent, especially in experimental evaluations. More 
experimental researching assessing the effects of DWI drug courts is clearly needed. For 
juvenile drug courts, the evidence generally finds small reductions in recidivism. More 
evaluations of juvenile drug courts, especially experimental and strong quasi-
experimental evaluations, are needed. 
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PLAIN LANGUAGE SUMMARY 
Drug courts are specialized courts in which court actors collaboratively use the legal and 
moral authority of the court to monitor drug-involved offenders’ abstinence from drug 
use via frequent drug testing and compliance with individualized drug treatment 
programs. The objective of this review was to systematically review quasi-experimental 
and experimental evaluations of the effectiveness of drug courts in reducing future 
offending and drug use. The systematic search identified 154 independent, eligible 
evaluations, 92 evaluations of adult drug courts, 34 of juvenile drug courts, and 28 of 
drunk-driving (DWI) drug courts. The findings most strongly support the effectiveness 
of adult drug courts, as even the most rigorous evaluations consistently find reductions 
in recidivism and these effects generally persist for at least three years. The magnitude of 
this effect is analogous to a drop in general and drug-related recidivism from 50% for 
non-participants to approximately 38% for participants. The evidence also suggests that 
DWI drug courts are effective in reducing recidivism and their effect on recidivism is 
very similar in magnitude to that of adult drug courts (i.e., a reduction in recidivism of 
approximately 12 percentage points); yet, some caution is warranted, as the few available 
experimental evaluations of DWI drug courts do not uniformly support their 
effectiveness. For juvenile drug courts we find considerably smaller effects on recidivism. 
The mean effect size for these courts is analogous to a drop in recidivism from 50% for 
non-participants to roughly 43.5% for participants
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1 Background 
The drug court model combines drug treatment with the legal and moral authority of the 
court in an effort to break the cycle of drug use and drug related crime (GAO, 1997; 
National Association of Drug Court Professionals, 1997). Briefly, a prototypical drug 
court operates as follows (National Association of Drug Court Professionals, 1997; 
Mitchell, 2011): Shortly after arrest, drug-involved offenders who appear to be eligible 
for drug court participation are identified and screened for program eligibility. Arrestees 
deemed eligible are offered entry into the drug court with an agreement that the charges 
against them will be reduced or dismissed upon successful program completion. 
Arrestees who agree to enter the drug court become drug court “clients.” Once in the 
drug court, clients have their cases handled non-adversarially in one of two ways. In the 
“pre-plea” case processing method clients waive their right to a speedy trial and enter 
drug court; if they successfully complete court requirements, then their charges are 
dropped. In the “post-plea” case processing method, clients are admitted to drug court 
after conviction but before sentencing. Clients who successfully complete the program 
typically receive a sentence of time served or probation.1
 
1 Some courts use both methods of case disposition for different groups of offenders. For example, Delaware 
used the diversionary approach with youthful, less criminally involved offenders, and the post-plea approach 
with more serious offenders. Those on the diversionary track were required to participate in drug court for 
six to twelve months; whereas, the more serious offenders on the post-plea track were required to be 
involved for longer periods of time. 
 As a condition of program 
entry, drug court clients agree to abide by the court’s demands, which typically include 
frequent urine testing, treatment attendance, and appearance before the court for status 
hearings. These status hearings are crucial as it is here that the drug court judge and 
clients converse directly, and it is in these hearings where judges in collaboration with 
other court actors most clearly use the authority of the court to motivate compliance. The 
court uses various rewards (e.g., praise, tokens of achievement, movement to the next 
phase of the program) and sanctions (e.g., increased treatment attendance or urine 
testing, short jail stays) to compel compliance to program requirements. Compliant 
clients advance through three or more, progressively less intense stages before 
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completing the drug court, which typically takes at least one year. Ultimately, successful 
drug court clients are acknowledged at a formal graduation ceremony. 
Drug court eligibility requirements vary across the thousands of jurisdictions operating 
such courts. In the majority of jurisdictions, however, eligibility is restricted to non-
violent offenders with evidence of substance dependence (Belenko, 1998). Most 
commonly, non-violent offenders are defined as offenders neither charged with, nor 
previously convicted of, a serious violent offense. While not all jurisdictions restrict 
eligibility to non-violent offenders, the vast majority of drug courts do, in part because 
this criterion is necessary to be eligible for federal drug court funding.2
It is important to emphasize that the program requirements for drug courts are often 
strict and clients are closely monitored for adherence to the demands of the program. 
Perhaps the best evidence of the rigor of the drug court model is the high percentage of 
drug court clients who fail to graduate from these programs. For example, a GAO survey 
of drug courts operating at the end of 1996 found that “about 48%” of drug court clients 
successfully completed the program (GAO 1997, p. 56). Similarly, Belenko’s (2001) 
review of drug court evaluations found an average graduation rate of 47% with a range of 
36% to 60%. Thus, the best estimate of drug court graduation rates is just under 50%.  
 Many courts also 
exclude arrestees charged with drug trafficking offenses, with three or more prior felony 
convictions, or with serious mental health issues (see e.g., Kalich & Evans 2006). In the 
end, most eligible offenders are charged with drug or property offenses and have 
relatively few prior felony convictions.  
Taken together, the key components of drug courts are: (1) collaborative, non-
adversarial, outcome driven court processing, (2) early identification of eligible 
offenders; (3) drug treatment integrated into criminal justice case processing; (4) urine 
testing; (5) judicial monitoring; and, (6) the use of graduated sanctions/rewards 
(National Association of Drug Court Professionals, 1997; Hora, 2002). These 
components combine to form individualized interventions that simultaneously provide 
drug treatment to drug abusing offenders and hold them accountable for their behavior. 
In just two decades, drug courts have gone from a single court in one jurisdiction to an 
international movement with thousands of courts in operation. Dade County Florida was 
the first jurisdiction to develop and adopt the drug court model described above. Dade 
County’s innovative drug court was viewed as a success and its approach has been widely 
adopted. In 1994, five years after the initial drug court was opened for operations, 40 
 
2 According to a 1997 GAO report (1997, p. 38), approximately 80% of drug courts operating at the end of 
1996 received federal funds; and therefore, at least 80% of drug courts restrict eligibility to non-violent 
offenders.  
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drug courts were in operation. Five years later, 472 courts were operating. By 2004, the 
number of operating drug courts stood at over 1,600 (Huddleson, Marlowe, & Casebolt, 
2008). The most recent data indicate that there were over 2,400 drug courts in operation 
in the United States (Huddleson & Marlowe, 2011). Drug courts have also spread to other 
nations such as Canada, the United Kingdom, New Zealand, Australia, South Africa, 
Bermuda, and Jamaica (Berman & Feinblatt, 2005).  
Not only have the number of drug courts increased, but also drug courts have increased 
in kind. Originally, drug courts were local courts that primarily served adult offenders 
with illicit substance abuse problems (“adult drug courts”). In recent years, however, 
drug courts for juvenile offenders and offenders charged with driving while under the 
influence (DWI) of alcohol have been opened and proliferated. Currently, there are 476 
juvenile and 172 DWI drug courts in operation (Huddleston & Marlowe, 2011). Further, 
the drug court model also has begun to make inroads in federal and tribal jurisdictions 
(Huddleston et al., 2008).3
It is interesting, albeit common in the criminal justice system, that drug courts’ initial 
expansion occurred without a solid body of empirical evidence establishing their 
effectiveness in reducing criminal behavior. In fact, an early review of the drug court 
literature conducted by the U. S. General Accounting Office (1997) concluded that the 
existing evidence was insufficient to draw any firm conclusion on the effectiveness of 
these programs with respect to recidivism. More specifically, the U. S. General 
Accounting Office (1997) identified several limitations of the 20 evaluations examined, 
including a failure to examine outcomes beyond program participation and a failure to 
use a comparison group design. Twelve of these evaluations included a comparison 
group and six of these examined recidivism post-program. Summarizing these studies, 
the GAO stated that: 
 
Some studies showed positive effects of the drug court programs during the period 
offenders participated in them, while others showed no effects, or effects that were 
mixed, and difficult to interpret. Similarly, some studies showed positive effects for 
offenders after completing the programs, while others showed no effects, or small 
and insignificant effects. (U. S. General Accounting Office, 1997, p. 85) 
A later review by Belenko (2001) drew a cautious but positive conclusion on the impact 
of drug courts on long-term drug use and criminal offending based on a review of 37 
evaluations. Not all of the evaluations reviewed by Belenko examined drug use or other 
 
3 The drug court model also has been applied outside of criminal courts; family drug courts are relatively 
new advents that handle family court issues (e.g., parental rights, allegations of neglect) in cases in which 
drug abuse is determined to be a factor. 
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criminal activity outcomes. Belenko was critical of the field’s dearth of evaluations that 
examined post-program drug use and other criminal behavior, noting that only six of the 
studies he reviewed examined the long-term effects of these programs. The process data 
reviewed by Belenko suggested that “drug courts have achieved considerable local 
support and have provided intensive, long-term treatment services to offenders with long 
histories of drug use and criminal justice contacts, previous treatment failures, and high 
rates of health and social problems” (Belenko, 2001, p. 1). 
In 2005, the GAO updated its review of drug court evaluations (U. S. General 
Accountability Office, 2005). This review examined 27 evaluations that used comparison 
groups (i.e., two-group designs) and this time concluded that the evidence indicates drug 
courts reduce recidivism in the period of time corresponding to the drug court treatment, 
but drug courts’ effects on recidivism beyond this period and on drug use were 
questionable. This study also reviewed four cost-benefit evaluations and concluded that 
drug courts do yield a net benefit. 
Most recently, Wilson, Mitchell, and MacKenzie (2006) synthesized the findings of 55 
drug court evaluations. These authors tentatively concluded that drug court participants 
have lower rates of recidivism (drug and non-drug offending) than similar offenders who 
did not participate in drug courts. These findings held for evaluations that measured 
recidivism during and after program participation. Like the earlier reviews, these 
findings were tempered by the generally weak methodological rigor of the evaluations.  
Taken together, existing reviews of drug court evaluations reveal growing support for the 
effectiveness of drug courts, especially during the period of program participation. Many 
questions, however, remain unresolved. First, it is still uncertain whether drug courts’ 
effects reliably persist beyond the period of program participation. Second, it is unclear 
whether juvenile drug courts and DWI drug courts are effective in reducing recidivism. 
Third, and most important, it is unclear which drug court features are associated with 
greater effectiveness in reducing recidivism. Drug courts differ in approach and structure 
and these differences may influence effectiveness. Longshore et al. (2001) provide a 
useful conceptual framework for thinking about variation in drug courts. They 
hypothesize that the most effective drug courts: (1) use the courts’ leverage (rewards and 
sanctions) to motivate offender change; (2) serve populations with less severe problems; 
(3) have high program intensity; (4) apply rewards and sanctions predictably; and, (5) 
emphasize offender rehabilitation as opposed to other court goals like speedy case 
processing and punitive sanctioning. This framework provides a potentially useful 
framework for attempting to understand variation in drug court effectiveness. 
Fortunately, numerous new evaluations have been completed in recent years. This ever-
expanding body of research permits an examination of these unresolved issues. 
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2 Objectives 
Our objective was to systematically review quasi-experimental and experimental 
evaluations of the effectiveness of drug courts with respect to future criminal offending 
and drug use behavior. This systematic review focused on estimating the effectiveness of 
these programs relative to “standard” criminal justice system case processing. The 
review critically assessed drug courts’ effects on recidivism in the short- and long-terms, 
the methodological soundness of the existing evidence, and the relationship between 
drug court features and effectiveness (i.e., what court features are associated with greater 
reductions in recidivism?). 
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3 Methods 
3.1  CRITERIA FOR INCLUSION AND EXCLUSION OF STUDIES 
IN THE REVIEW 
The population of evaluations eligible for this review was experimental and quasi-
experimental evaluations of drug courts that utilized a comparison group. In brief, the 
criteria for inclusion were that: (1) the evaluation examined a drug court program 
(defined as specialized courts for handling drug-involved cases that are processed in a 
non-adversarial manner, refer offenders to appropriate treatment programs, regularly 
test offenders for drug use, and have a judge who actively monitors progress and 
provides sanctions for misbehavior); (2) the evaluation included a comparison group 
that was treated in a traditional fashion by the court system (e.g., probation with or 
without referral to treatment); (3) the evaluations reported a measure of criminal 
behavior, such as arrest or conviction for some measurement period following the start 
of the program (the measure may have been based on official records or self-report and 
may have been reported on a dichotomous or continuous scale); and, (4) enough 
information was reported to compute an effect size. The form for establishing study 
eligibility is provided in Appendix A. 
In regards to the first eligibility criterion, our operational definition of a “drug court” 
included specialized courts or court dockets that fit the five essential features of drug 
courts listed above (see pages 6-7). The task of identifying drug courts was made easy by 
the fact that nearly all of the interventions meeting this criterion self-identified as an 
evaluation of a “drug court.” The only ambiguity regarding this criterion concerned 
speedy case processing drug courts (e.g., see Belenko, Fagan, Dumanovsky, and Davis, 
1993) and evaluations of the Breaking the Cycle (BTC) demonstration project (e.g., see 
Harrell, Mitchell, Hirst, Marlowe, and Merril, 2002). Speedy case processing drug courts 
were ruled ineligible because they focused on expedited case processing of drug cases, 
not substance abuse treatment with judicial monitoring of drug-involved cases. 
Evaluations of the BTC demonstration project were also ruled ineligible. While this 
intervention was based on the drug court model, a judge generally did not actively 
15 
 
monitor clients and most clients, rarely, if ever had a status hearing.4
The second criterion specified that all included evaluations must have a 
comparison/control group that received standard criminal justice processing. 
Essentially, this criterion required all evaluations to have a comparison and the 
comparison group received no drug treatment or minimal drug treatment. We excluded 
evaluations that compared drug court treatment to another drug treatment program of 
similar intensity (i.e., treatment-treatment comparisons or dose-response evaluations). 
Furthermore, we excluded evaluations in which the comparison group was comprised 
predominantly or solely of dropouts from the drug court. Evaluations that utilized 
program drop-outs as the comparison group were excluded because these represent a 
particularly weak research design with a serious threat to internal validity.  Those who 
drop-out from a drug-court are likely to differ from those who remain in a drug court on 
a host of important variables, some observable and others not (see e.g., Mateyoke-
Scrivner, Webster, Staton, Leukefeld, 2004). 
 Perhaps the 
clearest indication that BTC demonstration project was not a drug court program is the 
fact that a recent multi-site evaluation of drug courts used Pierce County’s BTC program 
as a non-drug court, comparison program (see Rossman, Rempel, Roman, Zweig, 
Lindquist, Green, Downey, Bhati, and Farole, 2011).  
The third and fourth criteria are largely self-explanatory. Simply put, eligible evaluations 
could use a wide variety of recidivism measures from official measures such as arrest, 
conviction, and re-incarceration to self-report measures of criminal offending. Last, all 
eligible evaluations had to report sufficient information for effect size calculation. 
3.2  SEARCH STRATEGY FOR IDENTIFICATION OF RELEVANT 
STUDIES 
The goal of the search strategy was to identify all evaluations, published or unpublished, 
meeting the above eligibility criteria. In order to achieve this objective, a multi-pronged 
search strategy was utilized. The search began by conducting a computerized keyword 
search of bibliographic databases.  In particular, we conducted a search of the following 
databases: NCJRS, Criminal Justice Abstracts, Dissertation Abstracts, PsycINFO, 
Sociological Abstracts, Social Science Citation Index, Sciences Citation Index Expanded, 
Arts & Humanities Citation Index, Conference Papers Index, Ingentaconnect, C2 
SPECTR, and CINAHL, as well as Google internet searches. The keywords used were: 
drug court (drug court*), DWI court (DWI court*), DUI court (DUI court*), evaluation, 
 
4 Note that the lead author was part of the team that evaluated BTC.  
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recidivism, re-arrest, and re-conviction. Each of the first three keywords was used in 
combination with each of the four latter terms.  
We also searched for eligible evaluations by carefully reading retrieved studies and 
existing reviews of drug court research for unfamiliar evaluations. In particular, we 
reviewed the reference lists of existing reviews of drug court evaluations to identify 
eligible evaluations (Belenko 2001, GAO, 1997; 2005; Latimer, Morton-Bourgon, & 
Chretien, 2006; Marlowe, Festinger, Arabia, Croft, Patapis, & Dugosh, 2009; Shaffer, 
2006, 2011) Likewise, many of the included evaluations reviewed prior drug court 
research. Unfamiliar studies referenced by eligible evaluations were also assessed for 
eligibility.  
Further, we searched websites of several prominent research organizations. Specifically, 
we searched for relevant research reports on the following websites: NPC Research 
(http://www.npcresearch.com/); National Drug Court Institute 
(http://www.ndci.org/ndci-home/); the Drug Court Clearinghouse via American 
University’s Justice Programs Office webpage (http://www1.spa.american.edu/justice-
old/index.php); RAND Drug Policy Research Center 
(http://www.rand.org/multi/dprc/); The Urban Institute’s website 
(http://www.urban.org/index.cfm); and, the University of Cincinnati’s School of 
Criminal Justice publications page (http://www.uc.edu/ccjr/reports.html). 
All studies that appeared to be eligible based on a preliminary review of the title and 
abstract were retrieved and closely scrutinized to determine final eligibility status. 
Specifically, we reviewed the title and abstract of each search result for clear evidence of 
ineligibility. Those studies that could not be ruled as ineligible based on the title/abstract 
review were retrieved for further assessment of eligibility. Retrieved studies were read 
closely to determine final eligibility status.  
Note that the last search was conducted in August 2011. Given our extensive search we 
are confident that we have identified the overwhelming majority of eligible evaluations. 
It is possible, however, that studies made available close to August 2011 may have been 
missed, as there often is a lag between the availability of a study and its appearance in 
bibliographic databases and search engines. 
3.3  DESCRIPTION OF METHODS USED IN THE COMPONENT 
STUDIES 
The basic research design used in eligible evaluations was a two-group (treatment and 
comparison group) design with a post-release outcome measure of interest, such as post-
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release criminal arrest or drug use. The comparison groups employed in eligible 
evaluations were constructed using a variety of methodologies including historical 
comparisons, drug-involved probationers from nearby jurisdictions, drug-involved 
offenders eligible for the treatment program who chose not to participate, eligible 
offenders who did not participate for a variety of reasons (e.g., not referred, rejected by 
program administrators), and random assignment. The included evaluations also varied 
widely in regards to the degree to which they employed statistical controls (matching, 
covariate analysis, etc.) to reduce the threat of selection bias. Our coding forms were 
designed to capture these methodological variations. 
3.4  CRITERIA FOR DETERMINATION OF INDEPENDENT 
STUDIES 
Several types of statistical dependencies were evident in evaluations of drug court 
programs. One common dependency was created by multiple measures of criminal 
behavior (e.g., re-arrest, re-conviction, drug use) or multiple follow-up periods for the 
same indicator of criminal behavior ups (e.g., 6 months, 12 months). Another common 
dependency was produced by multiple studies reporting findings from the same sample 
of research participants.   
The statistical methods detailed below required statistical independence. In other words, 
each evaluation had to use a unique research sample. We utilized several strategies to 
maintain the statistical independence. First, all evaluations (i.e., treatment/comparison 
contrasts) were cross-checked against one another to ensure that multiple studies 
reporting the results of the same evaluation do not contribute multiple estimates of 
program effects to any analysis.  Second, in evaluations that report multiple measures of 
criminal behavior, rather than averaging these multiple outcomes, we applied a set of 
selection criteria that created three data sets of effect sizes, with a particular evaluation 
contributing only one effect size to each of the data sets.5
 
5 If multiple effect sizes from were available from one evaluation and no one effect size met the selection 
criteria, as a last resort the available effect sizes were averaged. 
 In the first data set preference 
was given to effect sizes that: (1) were general (i.e., covered all offense types as opposed 
to being offense specific), (2) were based on arrest, (3) were dichotomous, and (4) 
followed sample members for 12 months. We preferred effect sizes meeting these 
criteria, because such effect sizes were the most commonly reported outcome measure. 
The goal here is to calculate one effect size from each evaluation meeting these criteria to 
maximize the comparability of recidivism measures across evaluations. If no such effect 
size was available, we selected the effect size that most closely matched these criteria. For 
example, property offenses were more general than violent offenses, effect sizes based on 
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re-convictions were preferred over re-incarcerations, and effect sizes following sample 
members closest to 12 months were preferred over other effect sizes. Each independent 
evaluation contributed one, and only one, effect size to this “general recidivism” data set. 
This general recidivism data set served as the main data set in the analyses that follow. 
We also created two other more specific data sets: one data set for measures of drug 
related recidivism (e.g., arrest or conviction on drug charges), and another data set for 
measures of drug use (via self-reports or drug tests). In creating these data sets we had 
considerably fewer effect sizes to choose from. When multiple effect sizes were available 
for any of these data sets, preference was given to effect sizes that: (1) were more general 
(e.g., encompassed multiple types of non-drug offending, instead of one specific type of 
non-drug offending), (2) were dichotomous, and (3) followed sample members for 12 
months. If an evaluation did not report one of these specific types of outcomes, then that 
evaluation did not contribute to the particular data set.  
3.5  DETAILS OF STUDY CODING CATEGORIES 
The coding forms employed in this review are provided in Appendix B. These coding 
forms were structured hierarchically, in order to explicitly recognize the nested nature of 
effect sizes within studies. Any number of effect sizes could be coded from each 
evaluation using these forms [see Lipsey and Wilson (2001) for a discussion of this 
issue]. 
The coding forms captured key features of the nature of the treatment, research 
participants, research methodology, outcome measures, and direction and magnitude of 
observed effects. Two coders assessed each study. Discrepancies between coders were 
resolved by the lead author.   
3.6 STATISTICAL PROCEDURES AND CONVENTIONS  
An effect size was calculated for each evaluation contrast. We utilized the odds-ratio 
effect size, as this type of effect size is the most appropriate effect size for dichotomous 
outcomes, like our preferred recidivism measure (Lipsey and Wilson, 2001). When 
continuous outcome measures best fit the effect size selection criteria (see section 3.4), 
the standardized mean difference effect size was used.  These effect sizes were coded in a 
manner such that positive effect sizes indicate the treatment group had a more favorable 
outcome than the comparison group (i.e., less recidivism or drug use).  
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Odds-ratio effect sizes and standardized mean difference effect sizes were combined 
using the methods developed by Hasselblad and Hedges (1995). Specifically, mean 
difference effect sizes were transformed to odds-ratios. 
Our analyses of these effect sizes utilized the statistical approach outlined by Lipsey and 
Wilson (2001). In particular, we used the inverse variance method and assumed that the 
true treatment effects varied as a function of both measured (i.e., coded study features) 
and unmeasured differences between studies, that is, a random-effects model.  
Our analyses employed Stata macro programs written by David B. Wilson.6
3.7 TREATMENT OF QUALITATIVE DATA  
 These macro 
programs calculated the random effects variance component discussed above and 
computed various statistics such as the overall mean effect and the homogeneity of 
effects statistic. We also used these macro programs to determine which study features 
were associated with observed study effects via meta-analytic analogs to analysis of 
variance and regression, assuming a mixed-effects model estimated via full-information 
maximum-likelihood (Raudenbush, 1994; Overton, 1998).  
We did not include qualitative research in this systematic review. In future updates to 
this systematic review, however, we are open to suggestions from and collaboration with 
researchers specializing in such techniques. 
 
6 As of this writing, these macro programs are available to the public at: 
http://mason.gmu.edu/~dwilsonb/ma.html 
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4 Findings 
4.1  DESCRIPTION OF ELIGIBLE STUDIES 
Our search found 370 potentially eligible studies. We retrieved 365 of the potentially 
eligible studies for further review. (The remaining five studies cannot be located.) Of the 
retrieved studies, 181 were eligible for this systematic review. Many of the eligible 
studies, however, utilized overlapping samples or the same sample in initial and follow-
up evaluations of one drug court. These 181 studies yielded 154 independent evaluations 
of drug court programs. These 154 eligible and independent evaluations form the sample 
for this systematic review. 
Tables 1-3 provide descriptive information on the evaluations and drug courts examined 
in this review.  Most of the drug court evaluations examined the effectiveness of adult 
drug courts (i.e., drug courts designed for adult illicit substance users). Ninety-two of the 
154 evaluations (60%) assessed adult drug courts. Another 34 (22%) evaluations 
examined juvenile drug courts and the remaining 28 (18%) evaluations probed DWI 
(driving while intoxicated) courts.  
All but eight of the eligible, independent evaluations examined U.S. drug courts. Four of 
the remaining evaluations examined adult drug courts in Australia. Two evaluations 
were of Canadian drug courts (Toronto and Vancouver). One evaluation assessed a 
juvenile drug court in New Zealand, and another examined an adult drug court in Guam.  
A majority of the evaluations have been conducted since 1999, enhancing the external 
validity of these evaluations to the contemporary criminal justice context, at least in the 
United States. 
Overall, this body of literature is methodologically weak with few randomized studies of 
each type of drug court and only a modest number of rigorous quasi-experimental 
studies of adult drug courts and juvenile drug courts.  This will be discussed in greater 
detail below in the context of the study findings. 
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The evaluations exhibited relatively little variation in terms of sample characteristics (see 
Table 3). Overwhelmingly, the samples used in these evaluations were composed 
predominantly of males. The vast majority of courts restricted eligibility to non-violent 
offenders. Approximately 25% of samples used in adult drug courts had minor criminal 
history; whereas, less than 10% of the samples in juvenile and DWI drug courts had 
minor criminal history, that is, they were mostly first-time offenders. 
4.2  OVERALL MEAN EFFECTS BY TYPE OF DRUG COURT 
We calculated effect sizes that measure drug courts’ effects on three outcomes: (1) 
general recidivism (typically measured as re-arrest for any offense), (2) drug related 
recidivism (typically measured as re-arrest for a drug offense), and drug use (usually 
measured as self-reported drug use or via urinalysis), for each type of court. Table 4 
displays the mean odds-ratio for each court type (adult, juvenile, and DWI) by outcome 
type (general recidivism, drug recidivism, and drug use).  The forest plots for the general 
recidivism effects are shown in Figures 2 through 4.  The forest-plots show a clear 
pattern of evidence favoring drug courts, with most studies observing effects favoring the 
drug court (88%, 70%, and 85%, for adult, juvenile, and DWI, respectively). The overall 
mean odds-ratio for the general recidivism measure is small to moderate in size and 
statistically significant for all three court types (mean odds-ratio of 1.66, 1.37, and 1.65, 
for adult, juvenile, and DWI, respectively). Relative to a 50% recidivism rate in the 
comparison group (a typical value), these odds-ratios translate into recidivism rates for 
the respective drug court groups of 37.6%, 42.2%, and 37.7%. Thus, on average 
participants in adult and DWI drug courts have recidivism rates approximately 12 
percentage points lower than non-participants, while on average participants in juvenile 
drug courts have recidivism rates approximately 8% lower than non-participants. 
The effects of these courts on drug related recidivism (i.e., drug related crimes) are very 
similar for adult and DWI drug courts with random effects odds-ratios of 1.70 and 1.65, 
respectively. However, for juvenile drug courts, the results on drug related recidivism 
outcomes were less encouraging. The mean odds-ratio was 1.06. In practical terms, this 
odds-ratio is essentially null, or a no-difference effect. Thus, the current evidence raises 
the possibility that juvenile courts are not effective in reducing drug related crime or that 
any effect that is produced is small. 
Surprisingly few evaluations assessed the effect of drug court participation on measures 
of actual drug use (i.e., urinalysis or self-reported drug use). We found only nine 
independent evaluations that reported useable post-program entry measures of drug use 
for both drug court participants and non-participants. Four of the nine effect sizes 
assessed the effect of participation in adult drug court programs, three were from 
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evaluations of juvenile drug courts, and the two remaining effect sizes were from 
evaluations of DWI drug courts. For each type of court, the average effect size was 
positive, indicating reduced drug use for drug court participants in comparison to non-
participants. However, because of the small number of drug use effect sizes, the average 
effect size for each type of court was not statistically significant.   
Although the evaluation of all three types of drug courts indicate that drug court 
participants have, on average, lower rates of general and drug recidivism than non-drug 
court participants, these findings need to be interpreted within the context of the 
methodological rigor of the studies.  As discussed below, this body of literature is 
generally weak methodologically. 
4.3  ROBUSTNESS OF FINDINGS TO METHODOLOGICAL 
WEAKNESSES 
Evaluations were placed into four categories: (1) weak quasi-experiments, (2) standard 
quasi-experiments, (3) rigorous quasi-experiments, and (4) randomized experiments. 
Rigorous quasi-experiments typically used subject-level matching on key variables or 
propensity score matching. Standard quasi-experiments typically used either a historical 
comparison group that met drug court eligibility criteria constructed from archival data 
or a group of offenders who were eligible but not referred to the drug court program. The 
critical feature here is that the participants did not self-select into the drug court or 
comparison condition.  Weak quasi-experimental designs typically involved comparing 
drug court clients to drug offenders who were eligible for participation in a drug court 
but declined participation (“refusers”) or were referred to the drug court but were 
rejected by drug court administrators (“rejects”). Such designs have questionable 
internal validity because refusers and rejects are likely to differ on factors like pre-
treatment motivation, perceived seriousness of drug problem, and self-efficacy, among 
many other potentially important factors. It’s important to note that evaluations that 
used refusers or rejects as the comparison group but included efforts to minimize 
selection bias (e.g., controlled for many variables in the analyses) were given higher 
ratings depending on the nature of the efforts to minimize selection bias. 
Tables 5-7 display the mean effect size by methodological features for general recidivism 
and drug recidivism. Focusing on adult drug courts, we find that the magnitude of the 
estimated effects of participation in adult drug courts generally declines as 
methodological rigor increases, but this relationship is not statistically significant. In 
particular, evaluations rated as weak or standard quasi-experiments found sizeable and 
statistically significant effects of drug court participation on measures of recidivism. 
These evaluations, however, are plagued by a substantial threat of selection bias. The 
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clearest evidence of the effectiveness of adult drug courts is provided by evaluations 
rated as strong (rigorous) quasi-experiments. The mean effect sizes for these evaluations 
are of a meaningful size and statistically significant.  
Of concern is the smaller average effects found in the three most rigorous, experimental 
evaluations of adult drug courts. In fact, for both general recidivism and drug recidivism, 
the mean odds-ratio for experimental designs is not statistically significant across the 
three experimental evaluations, and near the null value for drug related recidivism. 
These findings from these studies deserve greater exploration. The three randomized 
experimental evaluations of adult drug courts included in this synthesis evaluated: (1) a 
drug court in Maricopa County (Deschenes, Turner, & Greenwood, 1995; Turner, 
Greenwood, Fain, & Deschenes, 1999); (2) Baltimore City’s drug court (Gottfredon, 
Najaka, & Kearley, 2003; Gottfredon, Najaka, Kearley, & Rocha, 2006); and, (3) a drug 
court in New South Wales, Australia (Shanahan, Lancsar, Haas, Lind, Weatherburn, & 
Chen, 2004). All three evaluations reported findings on the effectiveness of drug court 
participation on measures of general and drug related offending in the first 12 months 
after program entry, which are the effects included in our primary analyses. The results 
for these experimental evaluations are inconsistent (heterogeneous), with two of the 
three evaluations finding modest positive results (odds-ratios of 1.65 and 1.82), and one 
evaluation (Deschenes et al., 1995) with a near null effect (1.06) on the general 
recidivism outcome measure, and two of the three studies finding small negative effects 
on the drug recidivism outcome measure (Deschenes et al., 1995, and Gottfredson et al., 
2003). Thus, the finding that experimental evaluations of adult drug courts do not 
collectively find statistically significant reductions in recidivism is driven by inconsistent 
results across the three evaluations and the small number of experimental evaluations 
(i.e., low statistical power), which is evidenced by the rather large confidence intervals 
around the mean effect sizes.  
All three evaluations have unique characteristics; however, the Maricopa County 
program had the unusual characteristic of comparing the drug court participants to a 
control group of offenders involved in a drug-testing program. In fact, the drug-testing 
control group was drug tested more often than the drug court group—a highly unusual 
finding in this body of research. Consequently, the evaluation of Maricopa County lacked 
a key feature of drug court evaluations, a treatment group that received more frequent 
drug testing that the comparison group. This fact, among others, makes this evaluation 
problematic. An important issue concerns the effect of this unique evaluation on the 
results reported in Table 5. We find that if this evaluation is removed for the analysis, the 
mean odds-ratio for experimental evaluations on the general recidivism outcome 
measure is 1.73 (95% C.I. of 1.18 to 2.53), which is statistically significant and larger than 
the effect for the rigorous quasi-experimental designs.  The mean odds-ratio for the drug 
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recidivism measure remains essentially unchanged (1.05, with a 95% confidence interval 
of 0.69 to 1.60). Another complication with the evaluation of the Maricopa County 
program is that the results changed substantively in a follow-up evaluation that reported 
outcomes three-years after program entry (Turner et al., 1999). In this subsequent 
evaluation, participants in the Maricopa County drug court program had significantly 
less recidivism (general and drug) than the control group. If the effect sizes from this 
subsequent evaluation are used instead of those from the original evaluation, then the 
mean odds-ratio for experimental evaluations is 1.65 (95% C.I. of 1.25 to 2.18) for general 
recidivism, which is statistically significant and virtually identical to the mean effect size 
for all evaluations of adult drug courts, and mean odds-ratio for drug recidivism is 1.19 
(95% C.I of 0.82 to 1.73), which is not statistically significant. Thus, the results of the 
Maricopa County evaluation materially affect the size and statistical significance of the 
mean odds-ratio for general recidivism, but not drug recidivism. 
We draw three conclusions from the above analyses. First and foremost, all three 
experimental evaluations of adult drug courts provide evidence of these courts’ 
effectiveness in reducing recidivism. Two of the three evaluations find recidivism 
reductions in the first year after program entry, and the remaining evaluation finds 
recidivism reductions at three years post-program entry. Second, because the vast 
majority of adult drug court evaluations, even the most rigorous evaluations, find 
moderate reductions in general recidivism, we believe that the evidence indicates that 
adult drug courts reduce recidivism. Third, the mean odds-ratio effect size measuring 
these courts effect on general recidivism appears to be approximately 1.65, which 
translates into an average recidivism rate of 38% for drug court participants, if we 
assume a 50% recidivism rate for non-participants.   
In regards to evaluations of juvenile drug courts, we find that these courts have small 
effects on recidivism, especially in methodologically rigorous evaluations. The strongest 
evidence of the effectiveness of juvenile drug courts comes from weak quasi-
experimental evaluations, as in these evaluations the general recidivism mean odds-ratio 
is relatively large (1.85) and statistically significant. However, the general recidivism 
mean odds-ratios are considerably smaller in evaluations with higher levels of 
methodological rigor. For standard quasi-experimental evaluations, the mean odds-ratio 
is 1.32 (95% C.I. of 1.07 to 1.62). The mean odds-ratios for strong (rigorous) quasi-
experimental and experimental evaluations are similar in magnitude 1.32 and 1.22, 
respectively; neither is statistically significant. However, if the rigorous quasi-
experimental and experimental evaluations are combined, the mean effect size is 1.28 
(95% C.I. of 1.03 to 1.61), which is statistically significant. These findings indicate that 
evaluations of juvenile drug courts reduce general recidivism, but the magnitude of these 
effects is smaller than that of adult drug courts. For drug related recidivism, juvenile 
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drug courts’ strongest effects are found in more rigorous evaluations, and in these 
evaluations the magnitude of the effect is similar to the general recidivism means odds-
ratio (approximately 1.30). Thus, the most rigorous evaluations of juvenile drug courts 
indicate that these courts have small effects on recidivism and the magnitude of these 
effects is approximately an odds-ratio of 1.30, which translates into a 43.5% recidivism 
rate for drug court participants, if we assume a 50% recidivism rate for non-participants.  
It is important to note that three evaluations of juvenile drug courts used experimental 
designs. Two of these evaluations assessed two different cohorts of participants in the 
Summit County (Ohio) Juvenile Drug Court (Dickie, No Date). These two evaluations 
had large attrition problems (both had more than 50% total attrition and one of the 
cohorts had significant differential attrition). Because of these attrition problems, we 
rated these two compromised experiments as strong quasi-experiments. Thus, the 
results presented in Table 6 for experimental designs are for the single high-quality 
randomized trial.  This study found positive effects, albeit not statistically significant, 
that are only slightly smaller than the overall effects for adult drug courts (i.e., an odds-
ratio of 1.39 for general recidivism and 1.38 for drug recidivism). If the two compromised 
evaluations are rated as experiments, our findings are essentially unchanged: the mean 
odds-ratio for general recidivism is 1.44. While the mean effect size is not statistically 
significant, it is important to note that the effect sizes from these three evaluations are all 
positive, indicating less recidivism for juvenile drug court participants. These findings 
continue to support the conclusion that juvenile drug courts have small effects on 
recidivism. 
The substantive findings regarding the effectiveness of DWI drug courts are similar to 
those for adult drug courts. Just as with evaluations of adult drug courts: (1) the largest 
effects of DWI drug courts are found in methodologically weak evaluations, (2) 
collectively, experimental evaluations find small and non-statistically significant mean 
odds-ratios for general and drug related recidivism; and, (3) the mean odds-ratios for 
experimental evaluations are greatly influenced by one evaluation that found a negative 
effect of participation. In regards to the first point, the mean odds-ratio is moderate and 
statistically significant for the three quasi-experimental design categories, but relatively 
small and non-statistically significant for the four evaluations in the experimental 
category (1.27 with 95% C.I. of 0.87 to 1.85). Thus, quasi-experimental evaluations yield 
substantively different findings than experimental evaluations of DWI drug courts. In 
regards to the second point, experimental evaluations find a small and non-statistically 
significant difference in general and drug related recidivism between participants and 
non-participants. And finally, additional analysis of the four experimental DWI drug 
court evaluations reveals that one such experimental evaluation conducted by 
MacDonald, Morral, Raymond, & Ebner (2007) heavily influences the mean odds-ratio 
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for the experimental evaluations. While the three other experimental evaluations of DWI 
courts found positive odds-ratios on the general recidivism measure ranging from 1.39 to 
2.25, MacDonald et al.’s evaluation found a negative effect (odds-ratio of 0.73). If 
MacDonald et al.’s evaluation is omitted from the general recidivism analysis, then the 
mean odds-ratio becomes 1.58 (95% C.I. of 0.99 to 2.54) and has a p-value of 0.057. 
Similarly, if this evaluation is omitted from the drug related recidivism analysis, the 
mean odds-ratio becomes 1.43 (95% C.I. of 0.83 to 2.50) with a p-value of 0.194. Thus, 
the MacDonald et al. evaluation is highly influential on the results of the experimental 
evaluations, especially the general recidivism analysis. 
The evidence presented above finds considerable evidence of the effectiveness of drug 
courts, but the strength of this evidence varies by type of court. In regards to adult drug 
courts, over 90 independent evaluations have been conducted and the overwhelming 
majority of these evaluations find that drug court participants have less recidivism than 
non-participants. Further, experimental evaluations of these courts also consistently find 
sizeable reductions in recidivism. Thus, the evidence indicates that adult drug courts are 
effective in reducing recidivism. Likewise, we characterize the evidence as cautiously 
supporting the effectiveness of DWI drug courts, because while quasi-experimental 
evaluations find strong and consistent indications that these programs reduce general 
and drug related recidivism, randomized experimental evaluations find a small, non-
statistically significant reduction in recidivism. Yet, the findings from experimental 
evaluations of DWI drug courts are ambiguous in that the majority of these evaluations 
find positive effects but a single, influential evaluation with negative findings heavily 
influences the mean effect. Clearly, only additional evaluations using experimental 
methods can definitively resolve the remaining ambiguity surrounding the effectiveness 
of DWI drug courts general effectiveness. Evaluations of juvenile drug courts, especially 
more rigorous evaluations, consistently indicate that these courts have relatively small 
effects on recidivism. 
4.4  DRUG COURTS’ LONG-TERM EFFECTS 
An important issue in drug court research is whether the effects last long-term.  
Assessing drug courts’ long-term effect, however, is challenging.  There are two inter-
related issues.  The first is whether the observed pattern of positive results reflects a 
suppression effect.  Many of the outcomes are examined for recidivism during the course 
of drug court participation.  It is possible that drug courts suppress offending behavior 
while someone is active in the program but that this effect disappears post-program once 
behavioral contingencies are removed.  The second issue is simply whether observed 
effects continue long-term, such as three years post-program. 
27 
 
We examined the first issue of suppression by coding whether the recidivism tracking 
period overlapped: (1) completely, (2) partially, or (3) not at all with the period of drug 
court participation. If drug courts’ effects on recidivism are limited to the period in 
which participants are active in the court, then the mean effect size should be largest 
when the treatment and recidivism tracking periods overlap completely and the mean 
effect size should decrease as the amount of overlap between the treatment and 
recidivism tracking periods decreases. Table 8 displays the mean effect size for each of 
these categories and shows that the effects of adult drug courts remain post-program.  
That is, the positive results do not appear to be simply a temporary suppression effect. 
We examined the second issue by computing mean effect sizes for different follow-up 
periods.  Recall that evaluations most commonly reported recidivism rates 12 months 
after drug court entry (or termination). When effect sizes measuring recidivism at 
multiple time points were available, we preferred effect sizes based on this most common 
time period (i.e., 12 months) to facilitate between study comparisons.  However, not all 
evaluations measured recidivism at 12-months and some evaluations reported recidivism 
at multiple time-points (e.g., 12, 24, and 36-months).  Consequently, there is variation 
both within and between studies in the length of recidivism tracking period. We exploit 
both sources of variation. Between study variation was examined by calculating the mean 
effect size by length of recidivism tracking period. These findings (Table 8) show a 
roughly stable mean odds-ratio for the different follow-up periods.  A complication with 
this analysis is the possible confounding of evaluation features with follow-up length.  To 
address that issue, we also examined within study variation by analyzing the subset of 
evaluations that reported results at both the 12 and 24 month follow-up period (21 
studies) and the subset of evaluations that reported results at the 12, 24, and 36 month 
follow-up period (8 studies).As shown in Table 8, adult drug court effects remain 
remarkable stable over time from 12-months through 36-months. 
The analyses presented above support the conclusion that any effect adult drug courts 
have on recidivism are not limited to the short-term. Rather, the available research 
suggests that drug court participants have reduced recidivism during and after drug 
court treatment, and these effects appear to last at least three years post-drug court 
entry. 
4.5  FEATURES OF THE DRUG COURT 
The various drug courts examined by this collection of evaluations vary in potentially 
important ways (see Tables 2 and 3).  We were guided by Longshore et al.’s conceptual 
framework for understanding differences across drug courts. 
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Longshore et al’s framework has five dimensions: leverage, population severity, program 
intensity, predictably, and rehabilitative emphasis. We were able to code measures 
tapping the first three dimensions. We were unable to code measures of the two latter 
concepts, because few evaluations reported the kinds of information necessary to 
measure these concepts. While we were able to code measures of leverage, population 
severity, and program intensity, many of our measures contain a large amount of missing 
data because evaluations often failed to provide relevant information (esp. regarding 
program intensity).  
Longshore and colleagues argued that drug courts in which participants face greater 
consequences if they fail to meet program requirements have greater leverage. For 
example, they contend drug courts that process cases using the post-plea method have 
greater leverage because offenders have been convicted and face immediate sentencing 
upon failure in drug court. Likewise, drug courts that dismiss charges or expunge 
convictions have greater leverage because such incentives are more attractive motivators 
than reductions in charges/sentences. Therefore, we coded courts’ method of case 
disposition (pre-plea, post-plea, or mixed) and what happens to the charges/sentences 
upon graduation (dismissed/expunged or not dismissed/expunged). Again evaluations 
often failed to report relevant information. However, when evaluations did report such 
information, post-plea case processing was most common (see Table 2). Further, most 
adult drug courts dismissed charges upon graduation, but dismissal was less common in 
juvenile and DWI drug courts.  
We found mixed support for the relationship between leverage and outcomes (Table 9).  
As anticipated, drug courts that dismiss/expunge charges upon graduation had higher 
mean odds-ratios on both measures of recidivism. This difference is statistically 
significant for the drug recidivism measure, but is non-significant for the general 
recidivism measure.  Counter to our expectations, however, drug courts that 
predominantly used post-plea case processing did not have greater reductions in 
recidivism than other courts.  
We coded multiple measures designed to tap program intensity, another aspect of 
Longshore et al.'s framework (see Table 2).  Moderator analyses of the relationship 
between coded measures of program intensity and effect size generally did not generally 
support the hypothesis that more intense programs are associated with greater 
reductions in recidivism (Table 9). In fact, most of these relationships reveal that the 
mean odds-ratios were substantively and statistically similar across the categories of the 
coded program intensity measures. One notable possible exception to this conclusion is 
the relationship between number of status hearings and effect size. The adult drug court 
analysis finds that courts with more than two status hearings in first treatment phase 
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had larger effects of drug related recidivism than other courts. Other than the number of 
status hearings, these findings suggest that drug courts with greater program intensity 
are no more effective in reducing recidivism than other courts.  
We replicated these analyses for juvenile and DWI drug courts (see Tables 10 and 11). 
These analyses were hindered by the relatively small number of evaluations of these 
programs and by missing data. Few differences were found. Yet, it is important to note 
that these analyses found that juvenile drug courts with more frequent status hearings 
had larger effects on general recidivism than other courts—a finding that is substantively 
similar to that found in the analysis of adult drug court evaluations. 
Perhaps most controversially, Longshore et al. hypothesize that drug court programs 
that serve less severe populations, in terms of criminal history and substance abuse 
problems, are more successful in reducing recidivism. This hypothesis is controversial as 
it directly contradicts a core element of Andrews et al.’s (1990) principles of effective 
intervention. One of Andrews et al.’s principles is that more effective programs serve 
more severe populations, and this “risk principle” has found empirical support (see e.g., 
Andrews & Bonta, 1992). To test the relationship between population severity and 
program effectiveness (i.e., effect size), we coded two measures of population severity. 
The first measure assessed whether offenders with violent criminal history were allowed 
into the program. The second measure concerned each sample’s extent of criminal 
history. Many drug courts also limit eligibility to offenders without extensive prior 
convictions. We inductively coded a measure flagging evaluations that used samples with 
limited criminal history. More specifically, we took notes on information relating to 
eligibility restrictions on criminal history and/or descriptive statistics concerning 
criminal history. After all evaluations were coded, we read over these notes and 
distinguished samples with relatively minor criminal history. For example, if 70% of the 
sample of drug court participants had no prior convictions or less than 3 prior arrests, 
then this sample was coded as having minor criminal history.  
Table 12 reports the mean odds-ratios by coded sample characteristics from evaluations 
of adult drug courts.  Analyses of the general recidivism effect sizes support Longshore 
and colleagues prediction. Specifically, samples that included only non-violent offenders 
had statistically larger mean odds-ratios on the general recidivism measure than samples 
that included violent offenders. Similarly, samples with minor criminal history had 
larger mean odds-ratios than evaluations based on samples with more criminal history; 
however, this difference was not statistically significant. These findings were not 
replicated in the analysis of the drug related recidivism outcome measure. Here there 
were no differences in the mean effects odds-ratios on either of the measures of 
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population severity. Thus, these findings are more supportive of Longshore et al.’s 
hypothesis than Andrews et al.’s risk principle. 
Again, we replicated these analyses for juvenile and DWI drug courts (see Tables 13 and 
14) and no meaningful relationships were between effect size and population severity. 
We also coded important drug features that are not directly related to Longshore et al.’s 
framework. One such measure is program graduation rate (see Tables 2 and 9). Here we 
found that most drug court participants do not successfully complete the program. The 
median graduation rate for adult, juvenile, and DWI drug courts are 39%, 47%, and 62%, 
respectively. Interestingly, for all three types of drug courts, we find a strong, non-linear 
relationship between graduation rate and both general and drug related recidivism. 
Specifically, Tables 9, 10, and 11 indicate that courts with graduation rates between 26% 
and 50% had substantively smaller effects on general and drug related recidivism than 
courts with either higher or lower graduation rates. Additional analyses (not shown in 
the tables) indicate that all of these differences are statistically significant (each has a p-
value less than 0.01). Thus, our results indicate that courts with graduation rates 
between 26% and above 50% had larger effects than courts with graduation in between 
these percentages.  It is unclear whether this reflects a feature of the drug court itself or 
of the client pool. 
Another potentially important measure is the network of treatment providers utilized by 
the drug court. Some research suggests that courts employing a single treatment 
provider are more likely to use cognitive-behavioral programs (Peyton & Gossweiler, 
2001), which have been shown to be relatively effective (MacKenzie, 2002, 2006). 
Additionally, the use of a single treatment provider may indicate stronger lines of 
communication between the court and the treatment providers. As such, courts using a 
single treatment provider may be more effective in reducing recidivism than other 
courts.  Despite these predictions, drug courts that utilize a single treatment provider 
had similar mean effect sizes as other courts.  
4.6  ADDITIONAL SENSITIVITY ANALYSES 
The majority of the evaluations included in this review were unpublished technical 
reports produced by government or private research entities. Such a large proportion of 
unpublished evaluations reduced the likelihood of publication bias affecting our 
estimates of drug courts’ effectiveness.  As shown in Table 5, the results for published 
and unpublished evaluations of adult drug courts were roughly similar.  This finding is 
also true for juvenile and DWI courts (see Tables 6 and 7).   
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Other forms of publication selection bias, such as outcome selection bias, may be 
present.  To assess whether our estimates were upwardly biased due to some form of 
publication bias, we performed the Duval and Tweedie trim-and-fill analysis for each 
court type. This method assumes that in the absence of publication bias, the scatterplot 
between effect size and standard error of the effect size will have a funnel shape and 
augments the data to achieve this shape. Using this method, the distribution of general 
recidivism effect sizes for adult drug court was filled with 23 effect sizes, which reduced 
the overall random effects mean odds-ratio from 1.66 to 1.34. The latter remained 
statistically significant (z = 5.18, p < 0.01). The distribution of drug recidivism effect 
sizes for adult drug courts did not require filling. For juvenile drug courts, the 
distribution of general recidivism effect sizes did not require filling but the distribution 
of drug recidivism was augmented with one additional effect size, which reduced the 
random effects means odds-ratio from 1.06 to 1.01 (neither was statistically significant). 
For the DWI drug courts, five effect sizes were added to the general recidivism 
distribution, which reduced the mean odds-ratio to 1.53 (z = 3.57, p < 0.01); two effect 
sizes were added to the drug related recidivism distribution, which reduced the mean 
odds-ratio to 1.57 (z = 4.59, p < 0.01). Thus, the conclusions remain robust even under 
the trim-and-fill model that tends to over-fill when there is substantial heterogeneity, as 
was the case here. 
We also performed sensitivity analyses to determine the effect on our results of allowing 
a few authors to contribute many effect sizes to our analyses. Specifically, we flagged 
authors who contributed 10% or more of the effect sizes to any of the court specific 
analyses, and then re-ran the analysis without these effect sizes. For adult drug courts, 
only NPC research contributed 10% or more of the effect sizes (k = 15). While the effect 
sizes from NPC had a larger mean odds-ratio effect size (1.94) than other evaluations 
(1.63), this difference was not statistically significant and the mean odds-ratio effect size 
for the other evaluations is virtually identical to the mean effect size with the NPC 
evaluations included. We performed similar analyses with the juvenile and DWI drug 
court effect sizes. These sensitivity analyses revealed that our results are substantively 
unchanged by multiple effect sizes from the same author(s).  
Last, we assessed the applicability of our findings beyond the United States by examining 
the eight international evaluations. Seven of the eight evaluations examined adult drug 
courts (1 in Guam, 2 in Canada, and 4 in Australia). Six of these seven evaluations had 
positive general recidivism effect sizes, four of which were moderate in size (odds ratio 
greater than 1.60), and the mean general recidivism odds-ratio is 1.62 with a 95% 
confidence interval of 1.11 to 2.36, which is statistically significant. Notice that this mean 
general recidivism odds-ratio is virtually identical to the mean odds-ratio reported above 
for all adult drug court evaluations (1.66). Only one international evaluation of a juvenile 
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drug court met our eligibility criteria; this evaluation assessed a juvenile drug court in 
New Zealand (Searle & Spier, 2006). This evaluation found a negative effect indicating 
that the juvenile drug court did not reduce recidivism. These international evaluations 
mirror our findings on adult and juvenile drug courts. Thus, our findings appear to 
accurately reflect existing evaluations of drug courts outside the United States.  
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5 Conclusions 
The rapid proliferation of drug courts across the United States has been remarkable. In 
approximately twenty years, drug courts have gone from a solitary court in one 
jurisdiction to a national phenomenon with thousands of courts in operation. The drug 
court phenomenon has become an international movement, as courts are now in 
operation in several nations. 
Perhaps even more remarkable has been the results of empirical evaluations of drug 
courts. The literature assessing the effectiveness of drug courts is large and diverse. As 
this synthesis reveals, the vast majority of evaluations of adult drug court programs find 
that participants in these programs have lower recidivism than non-participants, and 
often these differences are considerable. Our analyses indicate that on average the effect 
of participation in an adult drug court is equivalent to a reduction in general recidivism 
from 50% to approximately 38% and a reduction in drug-related recidivism from 50% to 
approximately to 37%; these reductions in recidivism persist for at least three years after 
program entry. Thus, the accumulated evidence suggests that adult drug courts are 
effective in reducing recidivism and the policy implication of this conclusion is that 
continued funding, development, and operation of adult drug courts is warranted. 
The evidence on the effectiveness of DWI drug courts is very promising but is not 
unambiguous, given the mixed and sometimes null findings from the most rigorous 
experimental evaluations. The magnitude of the effects is comparable to those of the 
adult drug courts. Yet, because of the ambiguous findings of the most rigorous, 
randomized experimental evaluations, we believe that additional experimental 
evaluations of DWI courts are needed. 
For juvenile drug courts, we find that these courts have considerably smaller effects on 
recidivism than either adult or DWI drug courts. Evaluations of these courts indicate 
that the average effect of participation in a juvenile drug court is equivalent to a 
reduction in recidivism from 50% to approximately 43.5%. This average effect is more 
than 40% smaller than the average estimated effects of participation in an adult or DWI 
drug court. The question becomes: Why are juvenile drug courts less effective than other 
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kinds of drug courts? Obviously, we cannot answer this question with certainty, yet two 
factors seem relevant. First, juvenile drug courts generally provide services to relatively 
high-risk offenders, whereas other kinds of drug courts typically exclude high-risk 
offenders. Second, juvenile drug courts appear to be less demanding interventions than 
adult drug courts, in that, drug testing and status hearings appear to be less frequent, 
and the period of program participation appears to be shorter in duration.  
Beyond these general conclusions about the effectiveness of drug courts, it is important 
to emphasize that the estimated effects of drug court participation are highly variable.  
This large variability in findings across evaluations suggests differential effectiveness 
across variations in drug courts.  We attempted to explore the sources of this variability 
by examining drug court structure, implementation, and participant characteristics.  Our 
analyses were informed by Longshore and colleagues (2001) framework for 
understanding differences across drug courts. We found some evidence supporting the 
importance of leverage in that drug courts that dismissed charges or expunged 
convictions had larger reductions in recidivism than other courts, but this finding was 
only meaningful for drug-related recidivism in the analysis of adult drug courts. 
Interestingly, we found relatively little variation in observable measures of program 
intensity, and courts that required more than the standard number of phases, drug tests 
were no more effective than other courts. This finding does not support Longshore and 
colleagues prediction regarding the relationship between program intensity and program 
effectiveness. The one finding that does support the importance of program intensity is 
the relationship between frequency of status hearings and program effectiveness. 
Specifically, courts with more than two status hearings in the first treatment phase 
exhibited larger reductions in recidivism than courts with two or fewer status hearings; 
however, this difference was only statistically significant for drug-related recidivism in 
the analysis of adult drug courts.  We believe that more primary research comparing the 
effectiveness of drug courts with varying features needs to be conducted to confirm these 
meta-analytic findings. 
In support of Longshore et al.’s conception framework of drug courts, we find that 
programs with less severe populations are more effective in reducing general recidivism. 
Specifically, evaluations of programs that only allowed non-violent offenders to 
participate had larger reductions in general recidivism than other program evaluations. 
This finding holds in various sensitivity analyses. Because this finding conflicts with the 
risk principle from Andrews et al.’s principles of effective intervention, it is sure to be 
met with considerable controversy and criticism. Yet, given the strength and consistency 
of this finding, we believe that this finding deserves consideration and further empirical 
scrutiny. 
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Our finding that courts with violent offenders are less effective in reducing general 
recidivism seems to contradict findings from other drug court researchers who have 
found that violent offenders perform as well in drug courts as non-violent offenders (see 
e.g., Saum, Scarpitti, & Robbins, 2001). Closer inspection, however, reveals that findings 
like Saum et al.’s examine a different unit of analysis than our meta-analytic research. In 
essence, these researchers work concerns the recidivism of individuals with evidence of 
prior violence in comparison to non-violent drug court participants; whereas, our meta-
analytic findings concern the reduction in recidivism between courts that allow violent 
drug court clients in comparison to other courts. These two questions are distinct and 
the answers to these questions need not match. As an example, consider the research of 
Saum et al. (2001), who as previously mentioned found that drug court participants with 
evidence of prior violence exhibited comparable reductions in recidivism as non-violent 
drug court participants. This study examines the individual-level of analysis. At the court 
evaluation-level of analysis, we find that the court evaluated in Saum et al’.s research 
(coded here under Scarpitti, Saum, and Robbins, 2001) had relatively small effects on 
recidivism in comparison to other drug court evaluations; in fact, this evaluation found 
that participants had more recidivism than non-participants. Rather than contradicting 
our finding, the results of Saum et al. buttress our conclusion that courts that accept 
violent offenders are less effective than other courts. In short, it is entirely possible that 
both sets of findings are correct; violent drug court participants do as well as non-violent 
participants in drug courts, and courts that accept violent offenders are less effective 
than other courts.  
While our finding regarding the inclusion of violent offenders will be controversial, it is 
important to note that this finding supports not only Longshore and colleagues’ 
theoretical perspective but also federal regulations that require drug courts to restrict 
eligibility to non-violent offenders in order to reach federal funds. Title V of the Violent 
Crime Control and Law Enforcement Act of 1994, for example, authorized federal 
funding of drug courts but prohibited the distribution of federal funds to drug courts that 
allow clients with current or prior serious violent convictions to participate (GAO 1997, 
p. 41). To our knowledge, this prohibition remains in place. Simply put, our results, while 
certainly not definitive, suggest that such restrictions have merit.  
One important issue, which goes beyond our current data, concerns whether drug courts 
restriction program eligibility in other ways, which may not be warranted. For example, 
courts exclude non-violent offenders currently charged or previously convicted of 
distribution/sales offenses from eligibility. Given that a large proportion of drug 
distribution/sales offenses are committed by drug users trying to support their expensive 
drug habits (see e.g., Johnson et al. 1985), such policies may exclude a substantial 
population of offenders who could benefit from drug court treatment. Likewise, many 
36 
 
courts also exclude drug abusing offenders with extensive criminal histories and serious 
mental health issues. While such offenders are obviously more of a risk to public safety, 
offering effective drug treatment to such offenders holds the promise of producing 
reductions in re-offending—which is precisely what the “risk principle” hypothesizes. 
There is some evidence outside of the drug court context that suggests expanding the 
drug court model to broader populations of offenders can be effective. Perhaps the most 
prominent example of this is found in the research of Adele Harrell and colleagues who 
evaluated the National Demonstration of the Breaking the Cycle (BTC) project. This 
project applied an intervention based on the drug court model to nearly all drug 
abusing offenders arrested on felony charges in three sites (Tacoma, WA, Birmingham, 
AL, and Jacksonville, FL). In spite of partial program implementation, the evaluation 
found that participation in the BTC was associated with reductions in criminal behavior 
(Harrell et al. 2002; Mitchell and Harrell 2006). The findings of the BTC demonstration 
project suggest that drug courts could be applied to a wider range of offenders and still 
reduce recidivism. Further, BTC’s findings are buttressed by a recent simulation analysis 
that indicates relaxing the eligibility criteria for criminal justice based drug treatment 
programs would substantially increase the number of offenders eligible for treatment, 
and this expansion would avert several million crimes that these offenders who 
otherwise commit (Bhati & Roman, 2010). Such research suggests that the adult drug 
court model could be expanded to include more serious, non-violent offenders and still 
reduce recidivism. 
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6 Plans for Updating the Review 
We plan to update this systematic review every three years in accordance with Campbell 
Collaboration guidelines. However, given the quantity of quasi-experimental evaluations 
and the consistency of their findings, we see little value in continuing to synthesis these 
evaluations. In the updated review, we plan to review only the findings of experimental 
evaluations.  
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10 Tables 
10.1  KEY FEATURES OF EVALUATIONS 
 
 
Variable 
Adult Drug Court  
(ka = 92) 
Frequency (%) 
Juvenile Drug 
Court (k = 34) 
Frequency (%) 
DWI Drug Court 
(k = 28) 
Frequency (%) 
Publication type    
  Journal/book chapter 21 (23%) 3 (9%) 4 (14%) 
  Unpublished 71 (77%) 31 (92%) 24 (86%) 
Publication year    
  1989-1993 1 (1%) 0 (0%) 0 (0%) 
  1994-1998 13 (14%) 1 (3%) 0 (0%) 
  1999-2003 41 (45%) 10 (29%) 4 (14%) 
  2004 or later 35 (38%) 14 (41%) 16 (57%) 
  No date 2 (2%) 9 (26%) 8 (29%) 
Outcome measure    
  General offending only 49 (53%) 20 (59%) 13 (47%) 
  Includes drug offending measure 39 (42%) 11 (32%) 13 (47%) 
  Includes drug use measure 4 (4%) 3 (9%) 2 (7%) 
Max length of follow-up    
  12 months or less  42 (46%) 18 (53%) 21 (75%) 
  12.01-24 months 23 (25%) 8 (24%) 2 (7%) 
  25.01-36 months 6 (7%) 2 (6%) 0 (0%) 
  36+ months 8 (9%) 4 (12%) 2 (7%) 
  No information/unclear 13 (14%) 2 (6%) 1 (4%) 
Follow-up overlap with treatment period    
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Variable 
Adult Drug Court  
(ka = 92) 
Frequency (%) 
Juvenile Drug 
Court (k = 34) 
Frequency (%) 
DWI Drug Court 
(k = 28) 
Frequency (%) 
  Complete overlap 26 (28%) 7 (21%) 5 (17%) 
  Partial overlap 46 (50%) 7 (21%) 14 (50%) 
  No overlap 17 (18%) 9 (26%) 8 (29%) 
  No information/Unclear 3 (3%) 11 (32%) 1 (4%) 
Methodological rigor rating    
  Weak quasi-experiment 18 (20%) 4 (12%) 3 (11%) 
  Standard quasi-experiment 51 (55%) 17 (50%) 7 (25%) 
  Rigorous quasi-experiment 20 (22%) 11 (32%) 5 (18%) 
  Random experiment  3 (3%) 1 (3%) 4 (14%) 
  No information/unclear 0 (0%) 1 (3%) 9 (32%) 
Type of comparison group used    
  Declined/rejected 28 (30%) 5 (15%) 1 (4%) 
  Historical controls 24 (26%) 7 (21%) 5 (18%) 
  Eligible non-referred 9 (10%) 0 (0%) 1 (4%) 
  Comparable (randomization) 3 (3%) 3 (9%) 5 (18%) 
  Regular probation 15 (16%) 10 (29%) 2 (7%) 
  Other Non-eligible drug offenders 9 (10%) 1 (3%) 5 (18%) 
  Not reported/can’t tell 4 (4%) 2 (6%) 9 (32%) 
Overall attrition>20%    
  Yes  4 (4%) 4 (12%) 3 (11%) 
  No 87 (95%) 28 (82%) 25 (89%) 
  No information/unclear 1 (1%) 2 (6%) 0 (0%) 
Differential attrition>20%    
  Yes 5 (4%) 3 (8%) 2 (7%) 
  No 87 (95%) 30 (88%) 26 (93%) 
  No information/unclear 1 (1%) 1 (3%) 0 (0%) 
a Number of evaluations 
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10.2  KEY FEATURES DRUG COURTS 
 
 
Variable 
Adult Drug Court  
(ka = 92) 
Frequency (%) 
Juvenile Drug 
Court (k = 34) 
Frequency (%) 
DWI Drug Court 
(k = 28) 
Frequency (%) 
Maturity of courtb    
  New (first two years of operation) 54 (59%) 17 (50%) 16 (57%) 
  Developing (third or fourth year) 12 (13%) 9 (27%) 0 (0%) 
  Mature (beyond fourth year) 10 (11%) 1 (3%) 0 (0%) 
  Not reported 16 (17%) 7 (21%) 12 (43%) 
Method of disposition    
  Pre-plea 21 (23%) 0 (0%) 0 (0%) 
  Post-plea 36 (39%) 18 (53%) 11 (39%) 
  Uses Both 13 (14%) 1 (3%) 1 (4%) 
  Not reported 22 (24%) 15 (44%) 16 (57%) 
Charges dismissed upon graduation    
  Yes 34 (37%) 8 (24%) 1 (4%) 
  No 19 (21%) 3 (9%) 12 (43%) 
  Not reported 39 (42%) 23 (68%) 15 (57%) 
Number of phases    
  Two 4 (4%) 0 (0%) 0 (0%) 
  Three 41 (45%) 7 (21%) 3 (11%) 
  Four 16 (17%) 16 (47%) 7 (25%) 
  Five 5 (4%) 0 (0%) 3 (11%) 
  Doesn’t use phases 2 (2%) 1 (3%) 1 (4%) 
  Not reported 24 (26%) 10 (29%) 14 (50%) 
Number of drug tests/weekc    
  Two or less 21 (23%) 5 (15%) 5 (18%) 
  More than two  16 (16%) 3 (9%) 1 (4%) 
  Not reported 55 (60%) 26 (74%) 22 (79%) 
Number of treatment meetings/weekc    
  Three or less 9 (10%) 2 (6%) 1 (4%) 
  More than three 6 (7%) 3 (9%) 1 (4%) 
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  Not reported 77 (84%) 29 (85%) 26 (93%) 
Number of status hearings/monthc    
  Two or less 19 (21%) 7 (21%) 8 (29%) 
  More than two 16 (17%) 3 (9%) 0 (0%) 
  Not reported 57 (62%) 24 (71%) 20 (71%) 
Min. time to graduation    
  Less than 12 months 20 (22%) 17 (50%) 4 (14%) 
  12 to 15 months 46 (50%) 13 (38%) 8 (29%) 
  More than 15 months 12 (13%) 0 (0%) 5 (18%) 
  Not reported 14 (15%) 4 (12%) 11 (39%) 
Graduation rated    
  .00 to .25 10 (11%) 1 (3%) 0 (0%) 
  .26 to .50 38 (41%) 15 (44%) 2 (7%) 
  .51 to .75 13 (14%) 10 (29%) 10 (36%) 
  More than .75 0 (0%) 0 (0%) 5 (18%) 
  Not reported 31 (34%) 8 (24%) 11 (39%) 
Single treatment provider    
  Yes 15 (16%) 3 (9%) 0 (0%) 
  No 28 (30%) 8 (24%) 5 (18%) 
  Not reported 49 (53%) 23 (68%) 23 (82%) 
 
a Number of evaluations 
b At beginning of evaluation period. 
c In first treatment phase of drug court. 
d Graduation rate is calculated as proportion of terminated
 
 clients who completed program successfully (i.e., 
excludes those currently active in program). 
10.3  KEY FEATURES OF SAMPLES 
 
 
Variable 
Adult Drug Court  
(ka = 92) 
Frequency (%) 
Juvenile Drug 
Court (k = 34) 
Frequency (%) 
DWI Drug Court 
(k = 28) 
Frequency (%) 
Gender composition    
  All male (90%+ male) 1 (1%) 2 (5%)  1 (4%) 
  Mostly male (60-90% male) 77 (84%) 32 (94%) 19 (68%) 
  Approx. equal (59-40% male) 7 (8%) 0 (0%) 0 (0%) 
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  Mostly female (39-10% male) 0 (0%) 0 (0%) 0 (0%) 
  All female (<10% male) 0 (0%)  0 (0%) 0 (0%) 
  Not reported 7 (8%) 0 (0%) 8 (29%) 
Offender type    
  Only non-violent offenders 72 (79%) 18 (53%) 23 (82%) 
  Includes violent offenders 16 (17%) 4 (12%) 0 (0%) 
  Not reported 4 (4%) 12 (35%) 5 (18%) 
Minor criminal history    
  Yes 22 (24%) 2 (6%) 2 (7%) 
  No 48 (52%) 17(50%) 14 (43%) 
  Not reported 22 (24%) 15 (44%) 12 (50%) 
a Number of evaluations 
 
10.4  MEAN RANDOM-EFFECTS ODDS-RATIO BY TYPE OF 
RECIDIVISM MEASURE 
  95% Confidence Interval    
Outcome Mean ES Lower Upper Q ka Tau2 
Adult drug courts      
  General recidivismb 1.66* 1.50 1.84 442.19* 92 0.178 
  Drug recidivismc 1.70* 1.39 2.08 323.98* 42 0.368 
  Drug use 1.45 0.92 2.28 15.78* 4 0.165 
Juvenile drug court       
  General recidivism 1.37* 1.15 1.63 66.31* 34 0.105 
  Drug recidivism 1.06  0.69 1.63 29.65* 14 0.357 
  Drug use 1.50 0.67 3.34 2.05 3 0.359 
DWI drug court       
  General recidivismd 1.65* 1.35 2.02 78.40* 28 0.159 
  Drug recidivisme 1.59* 1.22 2.09 16.84 14 0.054 
  Drug use 1.87 0.34 10.23 5.02* 2 1.227 
a Number of evaluations 
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b The mean effect size is 1.57 (95% C.I. 1.43-1.72), when three
c The mean effect size is 1.46 (95% C.I. 1.28-1.67), when 
 large positive effect sizes were removed.  
two
d The mean effect size is 1.63 (95% C.I. 1.33-1.99), when 
 large positive effect sizes were removed.  
one
e The mean effect size is 1.57 (95% C.I. 1.20-2.04), when 
 large positive effect sizes was removed. 
one
* p < 0.05 
 large positive effect sizes was removed. 
 
10.5  MEAN RANDOM EFFECTS ODDS RATIOS OF ADULT DRUG 
COURTS BY METHODOLOGICAL FEATURES 
 General Recidivism  Drug Recidivismb 
Variable Mean 95% C.I. kc  Mean 95% C.I. k 
Publication status 
QB = 0.05, df = 1, 
p = 0.828, tau2 = 0.220  
QB = 0.51, df = 1, 
p = 0.477, tau2 = 0.787 
  Published 1.63 1.29-2.07 21  1.97 1.23-3.16 15 
  Unpublished 1.68 1.48-1.91 71  1.59 1.11-2.27 28 
Recidivism data source 
QB = 0.00, df = 1, 
p = 0.998, tau2 = 0.220  
QB = 0.34, df = 1, 
p = 0.562, tau2 = 0.788 
  Arrest records 1.67 1.47-1.90 74  1.82 1.29-2.57 30 
  Other 1.67 1.33-2.10 22  1.52 0.92-2.51 13 
Comparisons declined/rejected drug 
court involvement 
QB = 0.06, df = 1, 
p = 0.800, tau2 = 0.197  
QB = 0.47, df = 1, 
p = 0.492, tau2 = 0.800 
  Yes 1.66 1.37-2.01 31  1.51 0.90-2.53 13 
  No 1.61 1.41-1.84 60  1.87 1.32-2.66 29 
Historical comparisons 
QB = 0.00, df = 1, 
p = 0.956, tau2 = 0.197  
QB = 0.06, df = 1, 
p = 0.803, tau2 = 0.807 
  Yes 1.62 1.31-2.01 24  1.66 0.97-2.82 13 
  No 1.63 1.44-1.85 67  1.79 1.27-2.54 29 
Overall attrition>20% 
QB = 0.52, df = 1, 
p = 0.471, tau2 = 0.220  
QB = 0.03, df = 1, 
p = 0.865, tau2 = 0.795 
  Yes 1.37 0.78-2.40 4  1.62 0.77-3.41 6 
  No 1.69 1.51-1.89 87  1.74 1.28-2.37 37 
Differential attrition>20% 
QB = 0.27, df = 1, 
p = 0.601, tau2 = 0.221  
QB = 0.01, df = 1, 
p = 0.965, tau2 = 0.796 
  Yes 1.95 1.09-3.46 4  1.76 0.59-5.30 3 
  No 1.66 1.49-1.87 87  1.72 1.28-2.31 40 
Methodological rigor rating 
QB = 2.35, df = 3, 
p = 0.504, tau2 = 0.212  
QB = 2.04, df = 3, 
p = 0.563, tau2 = 0.755 
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  Weak  1.97 1.54-2.54 18  2.05 0.98-4.27 6 
  Standard 1.63 1.40-1.89 51  1.53 1.00-2.33 20 
  Strong 1.57 1.25-1.97 20  2.07 1.28-3.33 14 
  Experimental 1.45 0.80-2.62 3  1.03 0.37-2.88 3 
a Number of evaluations 
b If two large positive effect sizes are removed, the substantive findings are nearly identical to these; 
however, the variance component shrinks to approximately 0.10. 
 
10.6  MEAN RANDOM EFFECTS ODDS RATIOS OF JUVENILE 
DRUG COURTS BY METHODOLOGICAL FEATURES 
 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
Publication status 
QB = 0.76, df
p = 0.383, tau2 = 0.093 
 = 1, QB = 0.24, df
p = 0.627, tau2 = 0.304 
 = 1, 
  Published 1.70 1.02-2.83 3 0.85 0.32-2.28 2 
  Unpublished 1.34 1.12-1.59 31 1.11 0.71-1.74 12 
Recidivism data source 
QB = 0.00, df = 1, 
p = 0.986, tau2 = 0.095 
QB = 0.09, df
p = 0.769, tau2 = 0.304 
 = 1, 
  Arrest records 1.37 1.15-1.63 31 1.10 0.68-1.78 10 
  Other 1.36 0.79-2.35 3 0.96 0.43-2.12 4 
Comparisons declined/rejected 
drug court involvement 
QB = 9.83, df = 1, 
p = 0.002, tau2 = 0.068  
  Yes 0.66 0.40-1.09 5 ----  ---- -- 
  No 1.49 1.25-1.76 27 ----  ---- -- 
Historical comparisons 
QB = 2.91, df = 1, 
p = 0.088, tau2 =  0.092 
 
 
  Yes 1.72 1.23-2.40 7 ----  ---- -- 
  No 1.24 1.01-1.52 25 ----  ---- -- 
Overall attrition>10% 
QB=0.02, df = 1, 
p =0.886, tau2 = 0.093 
QB = 1.11, df
p = 0.293, tau2 = 0.294 
 = 1, 
  Yes 1.27 0.66-2.44 4 2.67 0.46-15.66 2 
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  No 1.33 1.11-1.58 28 1.01 0.66-1.53 12 
Differential attrition>10% 
QB = 0.01, df = 1, 
p = 0.952, tau2 = 0.097 
QB = 1.11, df
p = 0.293, tau2 = 0.294 
 = 1, 
  Yes 1.38 0.68-2.77 3 2.67 0.46-15.66 2 
  No 1.35 1.13-1.61 30 1.01 0.66-1.53 12 
Methodological rigor rating 
QB = 3.14, df = 2, 
p = 0.208, tau2 = 0.062 
QB = 2.25, df
p = 0.133, tau2 = 0.236 
 = 1, 
  Weak  1.85 1.26-2.72 4 0.53 0.15-1.93 1 
  Standard 1.32 1.07-1.62 17 0.85 0.42-1.69 4 
  Strong 1.22 0.90-1.65 11 1.31 0.76-2.23 8 
  Experimental 1.39 0.50-3.85 1 1.38 0.37-5.07 1 
 
10.7  MEAN RANDOM EFFECTS ODDS RATIOS OF DWI DRUG 
COURTS BY METHODOLOGICAL FEATURES 
 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
Publication status 
QB = 0.19, df = 1, 
p = 0.661, tau2=0.165 
QB = 0.75, df = 1, 
p = 0.388, tau2=0.065 
  Published 1.50 0.91-2.46 4 1.38 0.87-2.14 3 
  Unpublished 1.69 1.35-2.12 24 1.76 1.23-2.51 11 
Recidivism data source 
QB = 0.74, df = 1, 
p = 0.389, tau2 = 0.158 
QB = 0.01, df = 0, 
p = 0.043, tau2 = 0.000 
  Arrest records 1.61 1.30-1.99 25 1.60 1.20-2.12 13 
  Other 2.20 1.11-4.34 3 1.57 0.44-5.60 1 
Comparisons declined/rejected 
drug court involvement 
QB = 0.02, df = 0, 
p = ., tau2 = 0.067  
  Yes 1.95 1.01-3.78 1 ----  ---- -- 
  No 1.85 1.47-2.39 18 ----  ---- -- 
Historical comparisons 
QB = 0.23, df = 1, 
p = 0.635, tau2 = 0.062 
QB = 1.86, df = 0, 
p = ., tau2 = 0.050 
  Yes 1.99 1.32-3.00 5 7.78 0.53-115.0 1 
  No 1.84 1.40-2.40 14 1.45 1.07-1.97 12 
61 
 
Overall attrition>20% 
QB = 1.33, df = 1, 
p = 0.250, tau2 = 0.155 
QB = 0.15, df = 0, 
p = ., tau2 = 0.062 
  Yes 2.58 1.18-4.65 3 1.38 0.63-3.04 1 
  No 1.60 1.30-1.97 25 1.63 1.21-2.19 13 
Differential attrition>20% 
QB = 0.61, df = 1, 
p = 0.435, tau2 = 0.162  
  Yes 2.40 0.92-6.26 2 ----  ---- ----  
  No 1.63 1.32-2.00 26 ----  ---- ----  
Methodological rigor rating 
QB = 21.76, df = 3, 
p = 0.001, tau2 = 0.000 
QB = 8.44, df = 2, 
p = 0.015, tau2 = 0.000 
  Weak  1.99 1.49-2.65 3 7.78 0.55-110.9 1 
  Standard 2.56 1.66-3.96 7 2.13 1.29-3.51 4 
  Strong 1.99 1.49-2.65 5 1.78 1.30-2.44 5 
  Experimental 1.15 0.79-1.67 4 1.03 0.70-1.51 3 
 
10.8  MEAN RANDOM EFFECTS ODDS RATIOS OF ADULT DRUG 
COURTS OVER TIME 
 General Recidivism  Drug Recidivism 
Between evaluation comparisons Mean 95% C.I. ka  Mean 95% C.I. k 
Recidivism measure overlaps with 
drug court 
QB = 1.66, df = 2, 
p = 0.435, tau2 = 0.213  
QB = 1.77, df = 2, 
p = 0.412, tau2 = 0.766 
  Complete overlap 1.57 1.27-1.94 26  1.35 0.71-2.56 8 
  Partial overlap 1.77 1.51-2.06 47  2.04 1.42-2.94 26 
  No overlap 1.49 1.16-1.92 18  1.41 0.74-2.69 8 
All Available Outcomes by Follow-up 
Length 
QB = 1.33, df = 3, 
p = 0.723, tau2 = 0.141  
QB = 6.39, df = 3, 
p = 0.094, tau2 = 0.807 
  12 months or less 1.62 1.37-1.92 43  1.50 0.92-2.46 15 
  12.01-24 months 1.65 1.31-2.07 26  1.56 0.62-3.93 4 
  24.01-36 months 1.70 1.09-2.66 6  3.72 1.92-7.20 8 
  36+ months 2.22 1.53-3.22 8  1.67 0.84-3.31 7 
Evaluations that measure recidivism 
at 12 and   24 months       
  12 months 1.74 1.40-2.17 21  ----- ----- -- 
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  24 months 1.66 1.38-1.98 21  ----- ----- -- 
Evaluations that measure recidivism 
at 12, 24, and   36 months       
  12 months 1.71 1.18-2.48 8  ----- ----- -- 
  24 months 1.72 1.29-2.29 8  ----- ----- -- 
  36 months 1.80 1.44-2.24 8  ----- ----- -- 
a Number of evaluations 
 
10.9  MEAN RANDOM EFFECTS ODDS RATIOS OF ADULT DRUG 
COURTS BY DRUG COURT FEATURES 
 General Recidivisma  Drug Recidivismb 
Variable Mean 95% C.I. kc  Mean 95% C.I. k 
Drug court maturity 
QB = 4.95, df = 2, 
p = 0.084, tau2 = 0.228  
QB = 3.43, df = 1, 
p = 0.064, tau2 = 0.979 
  New 1.86 1.59-2.16 55  2.21 1.44-3.39 24 
  Developing 1.32 0.97-1.79 12  1.09 0.50-2.35 7 
  Mature 1.63 1.17-2.27 10  1.61 0.22-11.81 1 
More than 3 phases 
QB = 0.29, df = 1, 
p = 0.657, tau2 = 0.188  
QB = 3.18, df = 1, 
p = 0.075, tau2 = 0.909 
  Yes 1.60 1.29-2.00 21  1.07 0.51-2.21 8 
  No 1.69 1.45-1.96 50  2.06 1.38-3.06 25 
More than 2 drug tests/week 
QB = 1.55, df = 1, 
p = 0.214, tau2 = 0.172  
QB = 0.06, df = 1, 
p = 0.802, tau2 = 0.109 
  Yes 1.42 1.11-1.81 16  1.46 1.07-2.00 7 
  No 1.62 1.32-1.99 24  1.41 0.99-2.02 6 
More than 2 status hearings/month 
QB = 0.05, df = 1, 
p = 0.816 tau2 = 0.176  
QB = 28.58, df = 1, 
p = 0.001, tau2 = 0.020 
  Yes 1.57 1.22-2.03 16  2.26 1.64-3.11 4 
  No 1.54 1.23-1.92 19  1.37 1.10-1.70 7 
More than 3 treatment 
meetings/week 
QB = 2.91, df = 1, 
p = 0.088, tau2 = 0.179  
QB = 1.48 df = 0, 
p = ., tau2 = 0.099 
  Yes 1.50 1.08-2.07 9  1.60 0.75-3.44 1 
  No 1.80 1.17-2.78 6  1.32 0.91-1.92 5 
Minimum time to graduation QB = 1.07, df = 2,  QB = 3.03, df = 2, 
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 General Recidivisma  Drug Recidivismb 
Variable Mean 95% C.I. kc  Mean 95% C.I. k 
p = 0.586, tau2 = 0.155 p = 0.220, tau2 = 0.765 
  Less than 12 months 1.58 1.29-1.94 22  1.54 0.82-2.86 9 
  12-15 months 1.77 1.54-2.03 47  2.03 1.41-2.92 25 
  More than 15 months 1.61 1.22-2.12 12  0.78 0.24-2.55 3 
Method of Disposition 
QB = 0.40, df = 2, 
p = 0.820, tau2 = 0.195  
QB = 5.50, df = 2, 
p = 0.064, tau2 = 0.819 
  Pre-plea 1.74 1.37-2.19 22  1.52 0.89-2.60 13 
  Post-plea 1.60 1.35-1.89 38  1.52 0.91-2.54 13 
  Uses both 1.57 1.19-2.06 13  4.51 1.97-10.33 6 
Charges dismissed upon 
graduation 
QB = 0.87, df = 1, 
p = 0.350, tau2 = 0.167  
QB = 6.18, df = 1, 
p = 0.013, tau2 = 0.020 
  Yes 1.65 1.40-1.95 36  1.54 1.35-1.76 19 
  No 1.50 1.21-1.86 20  1.21 0.97-1.49 7 
Graduation rate 
QB = 12.79, df = 2, 
p = 0.001, tau2 = 0.172  
QB = 10.18, df = 2, 
p = 0.006, tau2 = 0.082 
  .00-.25 1.91 1.38-2.64 11  1.40 0.98-2.01 5 
  .26-.50 1.41 1.20-1.64 39  1.29 1.06-1.57 17 
  .51-.75 2.17 1.65-2.87 14  2.48 1.48-4.17 2 
Single treatment provider 
QB = 0.00, df = 1, 
p = 0.984, tau2 = 0.182  
QB = 0.10, df = 1, 
p = 0.753, tau2 = 0.099 
  Yes 1.55 1.18-2.04 16  1.48 0.98-2.25 6 
  No 1.56 1.29-1.87 30  1.56 1.25-1.95 12 
a If three large positive effect sizes are removed, there are no substantive differences. 
b If two large positive effect sizes are removed, the substantive findings are highly similar to these; however, 
the variance component shrinks to 0.10 or less. 
c Number of evaluations 
 
10.10  MEAN RANDOM EFFECTS ODDS RATIOS OF JUVENILE 
DRUG COURTS BY DRUG COURT FEATURES 
 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
Drug court maturity 
QB = 4.91, df = 1, 
p =0.027, tau2 = 0.068 
QB = 8.91, df = 1, 
p =0.003, tau2 = 0.099 
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 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
  New 1.32 1.05-1.67 17 0.50 0.28-0.91 4 
  Developing 1.20 0.92-1.57 9 1.42 0.92-2.20 7 
  Mature 2.29 1.31-4.00 1 ----  ---- -- 
More than 3 phases 
QB = 0.15, df = 1, 
p = 0.700, tau2 = 0.124 
QB = 4.35, df = 1, 
p =0.037, tau2 = 0.169 
  Yes 1.27 0.98-1.65 16 1.32 0.85-2.07 8 
  No 1.18 0.84-1.66 8 0.59 0.32-1.11 4 
More than 2 drug tests/week 
QB = 0.61, df = 1, 
p = 0.430, tau2 = 0.112 
QB = 16.98, df = 0, 
p = ., tau2 = 0.000 
  Yes 2.03 1.47-2.81 2 0.53 0.22-1.26 1 
  No 1.31 0.69-2.47 1 1.82 0.99-3.33 2 
More than 2 status 
hearings/month 
QB = 4.86, df = 1, 
p = 0.027, tau2 = 0.101 
QB = 10.97, df = 0, 
p = ., tau2 = 0.111 
  Yes 1.65 1.06-2.56 3 0.53 0.18-1.57 1 
  No 1.43 1.00-2.04 6 1.68 0.71-3.98 2 
More than 3 treatment 
meetings/week 
QB = 18.44, df = 1, 
p = 0.000, tau2 = 0.036  
  Yes 2.03 1.53-2.69 4 ----  ---- -- 
  No 1.07 0.71-1.61 2 ----  ---- -- 
Minimum time to graduation 
QB = 0.07, df = 1, 
p = 0.795, tau2 = 0.100 
QB = 1.06 df = 1, 
p = 0.304, tau2 = 0.290 
  Less than 12 months 1.38 1.11-1.73 17 0.80 0.40-1.60 4 
  12-15 months 1.32 0.99-1.76 13 1.23 0.72-2.12 7 
  More than 15 months       
Method of Disposition 
QB = 1.45, df = 0, 
p = ., tau2 = 0.161  
  Pre-plea ----  ---- -- ----  ---- -- 
  Post-plea 1.26 0.98-1.63 18 ----  ---- -- 
  Uses both 0.58 0.17-2.00 1 ----  ---- -- 
Charges dismissed upon 
graduation 
QB = 1.63, df = 1, 
p = 0.202, tau2 = 0.113 
QB = 9.21 df = 0, 
p = ., tau2 = 0.000 
  Yes 1.71 1.22-2.40 8 0.46 0.23-0.91 2 
  No 1.35 0.85-2.13 3 1.10 0.47-2.53 1 
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 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
Graduation rate 
QB = 10.86, df = 1, 
p = 0.001, tau2 = 0.054 
QB = 5.93, df = 1, 
p = 0.015, tau2 = 0.178 
  .00-.25 2.29 1.38-3.80 1 ----  ---- -- 
  .26-.50 1.11 0.88-1.40 15 0.76 0.47-1.22 7 
  .51-.75 1.63 1.24-2.13 10 2.01 0.97-4.18 3 
Single treatment provider 
QB = 0.15, df = 1, 
p = 0.699, tau2 = 0.105 
QB = 22.19 df = 0, 
p = ., tau2 = 0.000 
  Yes 1.62 0.79-3.35 3 3.19 1.32-7.72 1 
  No 1.46 1.11-1.93 8 0.77 0.42-1.41 2 
 
10.11  MEAN RANDOM EFFECTS ODDS RATIOS OF DWI DRUG 
COURTS BY DRUG COURT FEATURES 
 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
Drug court maturity     
  New ----  ---- -- ----  ---- -- 
  Developing ----  ---- -- ----  ---- -- 
  Mature ----  ---- -- ----  ---- -- 
More than 3 phases 
QB = 4.77, df = 1, 
p = 0.03, tau2 = 0.000 
QB = 0.094, df = 1, 
p = 0.760, tau2 = 0.000 
  Yes 2.37 1.67-3.32 10 1.87 1.21-2.88 7 
  No 1.87 1.41-2.48 4 1.74 1.30-2.31 3 
More than 2 drug tests/week 
QB = 1.13, df = 0, 
p = ., tau2 = 0.000  
  Yes 1.24 0.36-4.22 1 ----  ---- -- 
  No 1.70 1.35-2.13 6 ----  ---- -- 
More than 2 status 
hearings/month 
 
 
 
 
  Yes ----  ---- -- ----  ---- -- 
  No ----  ---- -- ----  ---- -- 
More than 3 treatment   
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 General Recidivism Drug Recidivism 
Variable Mean 95% C.I. k Mean 95% C.I. k 
meetings/week 
  Yes ----  ---- -- ----  ---- -- 
  No ----  ---- -- ----  ---- -- 
Minimum time to graduation 
QB = 0.24, df = 2, 
p = 0.887, tau2 = 0.0112 
QB = 2.29, df = 2, 
p = 0.318, tau2 = 0.064 
  Less than 12 months 1.82 1.05-3.15 4 1.29 0.60-2.73 2 
  12-15 months 1.89 1.24-2.88 8 2.05 1.02-3.21 7 
  More than 15 months 1.70 1.08-2.70 5 1.33 0.87-2.03 3 
Method of Disposition 
QB = 0.69, df = 0, 
p = ., tau2 = 0.102 
QB = 0.37, df = 0, 
p = ., tau2 = 0.063 
  Pre-plea ----  ---- -- ----  ---- -- 
  Post-plea 1.74 1.25-2.42 11 1.42 1.01-2.00 9 
  Uses both 3.21 0.79-13.09 1 0.66 0.06-7.59 1 
Charges dismissed upon 
graduation 
QB = 5.77, df = 0, 
p = ., tau2 = 0.109 
 
 
  Yes 5.05 1.08-23.70 1 ----  ---- -- 
  No 1.73 1.25-2.46 12 ----  ---- -- 
Graduation rate 
QB = 12.89, df = 2, 
p = 0.002, tau2 = 0.000 
QB = 2.09, df = 1, 
p = 0.149, tau2 = 0.000 
  .00-.25 ----  ---- -- ----  ---- -- 
  .26-.50 1.15 0.66-2.00 2 ----  ---- -- 
  .51-.75 2.12 1.57-2.84 10 1.84 1.29-2.65 6 
  .75+ 1.73 1.29-2.33 5 1.31 0.76-2.26 4 
       
Single treatment provider   
  Yes ----  ---- -- ----  ---- -- 
  No ----  ---- -- ----  ---- -- 
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10.12  MEAN RANDOM EFFECTS ODDS RATIOS FOR ADULT 
DRUG COURTS BY SAMPLE CHARACTERISTICS 
 General Recidivisma  Drug Recidivismb 
Variable     Mean 95% C.I. kc      Mean 95% C.I. k 
Gender composition f sample 
QB = 1.63, df = 1, 
p = 0.202, tau2 = 0.124  
QB = 1.59, df = 1, 
p = 0.207, tau2 = 0.249 
  All male (90%+ male) 1.55 0.44-5.50 2  ----- ----- -- 
  Mostly male (60-90%) 1.61 1.46-1.77 79  1.74 1.28-2.36 37 
  Approx. equal (59-40%) 2.06 1.42-2.97 8  0.84 0.14-5.13 2 
Offender type 
QB = 7.38, df = 1, 
p = 0.007, tau2 = 0.147  
QB = 0.03, df = 1, 
p = 0.856, tau2 = 0.749 
  Non-violent only 1.68 1.51-1.86 70  1.63 1.19-2.24 34 
  Includes violent offenders 1.25 1.03-1.52 16  1.74 0.93-3.26 8 
 
Minor criminal history 
QB = 2.91, df = 1, 
p = 0.088, tau2 = 0.130  
QB = 0.15, df = 1, 
p = 0.700, tau2 = 0.000 
  Yes 1.80 1.48-2.20 23  1.52 0.75-3.07 8 
  No 1.51 1.33-1.72 50  1.75 1.18-2.60 27 
a Three large positive effect sizes were removed. 
b If two large positive effect sizes are removed, there are no substantive differences. 
c Number of evaluations 
 
10.13  MEAN RANDOM EFFECTS ODDS RATIOS OF JUVENILE 
DRUG COURTS BY SAMPLE CHARACTERISTICS 
 General Recidivism Drug Recidivism 
 Mean 95% C.I. k Mean 95% C.I. k 
Gender composition of sample 
QB = 0.96, df = 1, 
p = 0.327, tau2 = 0.089 
QB = 1.59, df = 1, 
p = 0.207, tau2 = 0.249 
  All male (90%+ male) 0.96 0.46-2.00 2 1.90 0.71-5.11 2 
  Mostly male (60-90%) 1.40 1.18-1.65 32 0.95 0.62-1.45 12 
  Approx. equal (59-40%) ----  ----  -- ----  ----  -- 
Offender type 
QB = 0.04, df = 1, 
p = 0.839, tau2 = 0.095 
QB = 0.01, df = 0, 
p = ., tau2 = 0.000 
  Non-violent only 1.50 1.20-1.88 18 0.58 0.35-0.96 5 
  Includes violent offenders 1.57 0.98-2.50 4 0.59 0.17-2.03 1 
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Minor criminal history QB = 0.11, df = 1, 
p = 0.736, tau2=0.136 
  
 
  Yes 1.22 0.59-2.54 2 ----  ----  -- 
  No 1.35 1.04-1.76 17 ----  ----  -- 
 
10.14  MEAN RANDOM EFFECTS ODDS RATIOS OF DWI DRUG 
COURTS BY SAMPLE CHARACTERISTICS 
 General Recidivism Drug Recidivism 
 Mean 95% C.I. k Mean 95% C.I. k 
Gender composition of sample 
QB = 23.83, df = 0, 
p = ., tau2 = 0.000 
QB = 8.60, df = 0, 
p = ., tau2 = 0.000 
  All male (90%+ male) 0.73 0.42-1.27 1 0.73 0.42-1.27 1 
  Mostly male (60-90%) 1.91 1.61-2.25 19 1.80 1.42-2.28 12 
  Approx. equal (59-40%) ----  ---- -- ----  ---- -- 
Offender type   
  Non-violent only ----  ---- -- ----  ---- -- 
  Includes violent    
  offenders ----  ---- -- ----  ---- -- 
Minor criminal history QB = 1.955, df = 1, 
p = 0.213, tau2 = 0.100 
QB = 0.01, df = 0, 
p = ., tau2 = 0.101 
  Yes 1.40 0.54-3.64 2 1.57 0.42-5.93 1 
  No 2.10 1.58-2.79 14 1.64 1.14-2.35 10 
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11 Figures 
11.1  NUMBER OF U.S. DRUG COURTS, 1989-207 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Huddleston, Marlowe, and Casebolt (2008)
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11.2  FOREST PLOT OF GENERAL RECIDIVISM EFFECT SIZES FOR ADULT DRUG COURTS  
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11.3  FOREST PLOT OF GENERAL RECIDIVISM EFFECT SIZES FOR JUVENILE DRUG COURTS 
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11.4  FOREST PLOT OF GENERAL RECIDIVISM EFFECT SIZES FOR DWI DRUG COURTS 
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12 Appendices 
12.1  ELIGIBILITY FORM 
|___|___|___|  Document Identification Number 
 
_______________   First Author's Last Name 
 
 
yes no 
|__| |__| This study assessed a drug court program  
  Note
 
: A drug court is defined as a specialized court that combines 
substance abuse treatment, frequent UA testing, and judicial 
monitoring of client progress. 
|__| |__| This study included a comparison group that received either (a) no 
treatment, (b) treatment as usual, or (c) a minimal treatment 
intervention that is clearly hypothesized to be less effective. 
 
|__| |__| This study reported a post-program entry measure of drug use and/or 
criminal behavior that is measured in the same manner for both 
groups. 
 
|__| |__| This study reported sufficient information to calculate an effect size 
 
[If “yes” to all of the above, then mark this study as “eligible” in the database] 
 
------------------------------------------------------------------------------------------------- 
|__| |__| The study is ineligible but it is a review article that is relevant to this 
project. 
[if "yes" to the above question, then mark this document as a “relevant review” in the 
database] 
[If “no” to all of the above questions, then mark this study as “ineligible” in the 
database] 
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12.2  CODING FORMS 
 
12.2.1 Study Level Code Sheet 
Identifying Information 
Study (document) identifier [StudyID]  
If multiple documents were used to code this study, indicate the supplemental study ID 
numbers 
Cross references document identifier [CROSREF1]  
Cross references document identifier [CROSREF2]  
Cross references document identifier [CROSREF3]  
Coder’s initials [Coder]  
Date coded [Date]  
Author:  [Author] 
Publication type [PubType]  
1   Book 4   Gov’t Report, State/local 
2   Book Chapter 5   Journal (peer reviewed) 
3   Gov’t Report, Federal 6   Unpublished (tech report, convention paper, dissertation 
Year of publication:  
Number of different “modules” included in report [MODS]  
Is the same control/comparison group used in different 
modules? (1 = Yes; 0 = No) 
[SAME_CG]  
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12.2.2 Treatment-Comparison Contrast Level Code Sheet 
A study may report on multiple independent evaluations, such as independent treatment and 
control group contrasts, or may have a design that includes multiple interventions of interest 
contrasted with a single control group.  Each of these treatment/control contrasts of interest 
is treated as a separate “module” for coding purposes.  Note that the treatment groups across 
modules must have independent (non-overlapping) subjects.  A single control group may be 
used in more than one module. 
 
 
Identifying Information 
Study (document) identifier [StudyID]  
Module identifier [ModID]  
Coder’s initials [CoderMod]  
 
Name/Jurisdiction of drug court: (text)     [DC_Name]  
Year first opened (i.e., first client admitted): (text)   [YearOpen] 
Program description: (text)                  [ProgDes1] 
 
Type of drug court [DC_Type]  
1 Adult drug court (i.e., adults with illicit substance abuse problems) 
2 Juvenile drug court 
3 DWI/DUI drug court (i.e., offenders predominantly charged with DWI/DUI offenses) 
 
 
Court features 
Number of phases (0 = if doesn’t use phases, -99 = not  
reported) 
[Phases]  
Number of drug tests per week in phase 1 (-99 = not reported) [UAs]  
Number of treatment meetings/week in phase 1  
Note: AA/NA are not counted. (-99 = not reported) 
[TxMeet]  
Number of status hearings/month in phase 1 (-99 = not reported) [StatHear
] 
 
Graduation rate (number of graduations divided by number of 
terminated clients) (-99 = not reported) 
[GradRat
e] 
 
 
What happens to charges/sentence upon graduation? [GradChrg]  
1 Dismissed/Expunged 
2 Reduced 
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3 Discretionary (i.e., judge decides on case-by-case basis) 
9 Not reported 
 
One treatment provider [OneTreatr]  
0 No (multiple providers) 
1 Yes 
9 Not reported 
 
Method of case processing [CaseProc]  
1 Pre-plea  
2 Post-plea 
3 Uses both pre- and post-plea case processing 
9 Not reported 
 
Length of primary intervention in months (weeks/4.3) 
a Minimum [TxMon1]  
b Maximum [TxMon2]  
c Mean [TxMon3]  
d Fixed (same for all subjects) [TxMon4]  
Length of aftercare or follow-up program component (weeks/4.3) [TxAfterM]  
 
 Describe the program for the comparison group if 
other than no treatment or treatment as usual.  
 
[ProgDes 2]  
           (text)   
 
What happens to the comparison group? [CompGrp]  
1 No treatment 
2 Historical controls 
3 Eligible but not referred to drug court 
4 Treatment as usual (e.g., probation) 
5 Random assignment 
6 Other 
9 Cannot tell 
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Methodological Rigor 
Use of control variables in statistical analyses to account for 
initial group differences (1=Yes; 0 = No) 
[CntrlVar]  
Use of random assignment to conditions (1=Yes; 0 = No)  [Random]  
Use of subject level matching (1=Yes; 0 = No) [Matching]  
Measurement of prior criminal involvement; not necessarily 
arrest (1=Yes; 0 = No) 
[PreTest]  
 
Rating of initial group similarity (7=highly similar; 1=highly 
dissimilar) 
[SimRate]  
Anchors: 7 Randomized design large N or small N with matching 
 5 Nonrandomized design with strong evidence of initial equivalence 
 1 Nonrandomized design, comparison group highly likely to be different 
or known different that are related to future recidivism 
 
Was attrition discussed in the study reported? (1=Yes; 0 = No)   [Attrit1]  
 
Is there a potential generalizability threat from overall attrition? 
 
[Attrit2]  
0 No 8 N/A, no attrition problem 
1 yes 9 cannot tell 
 
Is there a potential threat from differential attrition?    [Attrit3]  
(same as above) 
Did the statistical analysis of outcome effects attempt to control for 
differential attrition effects? 
[Attrit4]  
(1=Yes; 0=No; 8=NA) 
 
Use of statistical significance testing (1=Yes; 0 = No)   [SigTest]  
 
Maryland methodology rating (see Maryland scale) [MethScor]  
2 A comparison group is present but lacks comparability to the treatment group 
3 A comparison group is present but differs slightly from the program group 
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4 A comparison group is present and it is very similar to program group, or a 
comparison group is present but it differs slightly from the program group, however, 
the data analysis controls for observed differences, or random assignment with large 
attrition 
5 Random assignment and analysis of comparable program and comparison groups, 
including controls for attrition 
 
Notes on Methodology 
(text) 
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12.2.3 Level Code Sheet 
Since a study may report results separately for distinct samples, a sample is a separate “level” 
in the coding scheme.  For example if a study reports the results separately for  
 
 
Identifying Information 
Study (document) identifier [StudyID]  
Module identifier [ModID]  
Sample identifier (Note: each sample within a study gets a unique 
number) 
[SampID]  
Coder Initials [CoderSmp]  
 
 
Sample Description 
Sample description treatment group (extent of prior history,             [SampDes1] 
mean number of arrests, convictions, etc.)                 
     (Text) 
 
Sample description comparison group (location, level of security,                       [SampDes2] 
prior history, etc.) 
    (Text) 
 
Total number of individuals in treatment group at beginning of study [TxN]  
Total number of individuals in comparison group at beginning of study [CgN]  
Note: Above must equal the total sample size prior to any attrition.  If multiple samples per 
module are being coded, the sum across samples must equal the total sample size prior to 
any attrition. 
 
Approximate age range of study participants [Age]  
1 Adolescent (12 to 18)  4 Adolescent and young adult 
2 Young Adult (19 to 25)         5 Adolescent and adult 
3 Adult (18+)                            9 Unspecified or cannot tell 
 
Young age included in sample (99 if unknown) [YngAge]  
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Oldest age included in sample (99 if unknown) [OldAge]  
Exact proportion of males in sample if reported [Males]  
       
Approximate gender description of sample [Sex]  
1 All males (>90%) 
2 More males than females (60% to 90% males) 
3 Roughly half males and half females 
4 More females than males (60% to 90% females) 
5 All females (>90%) 
9 Cannot tell 
 
Offender type general categories [SampType]  
1 Violent, person crimes 
2 Nonviolent, nonperson crimes 
3 Mixed 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82       The Campbell Collaboration | www.campbellcollaboration.org 
12.2.4 Outcome (DV) Level Code Sheet 
 
Identifying Information  
Study (document) identifier [StudyID]  
Outcome identifier (each coded outcome within a study gets a 
unique number) 
[OutID]  
Coder Initials [CoderDV]  
 
 
Outcome Information 
Outcome label (label used in report)       
 [label] 
 (text) 
 
Recidivism construct represented by this measure (1=Yes; 0 = No)   
A)  
A Arrest [DV1]  
b Conviction [DV2]  
c Reinstitutionalization / reincarceration [DV3]  
d Revocation [DV4]  
e Technical supervision violation [DV5]  
f Drug use [DV6]  
g Other indicator of criminal involvement [DV7]  
 
Specific types of offenses included in recidivism measure  (1=Yes; 0 = No)   
B) 
A All offenses [DVType1]  
b Drug offenses (including measures of drug use) [DVType2]  
c Person offenses, sexual [DVType3]  
d Person offenses, nonsexual [DVType4]  
e Person offenses, unspecified [DVType5]  
f Property offenses [DVType6]  
g Technical supervision or status offense [DVType7]  
h Other:  [DVType8]  
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Type of measurement scale [Scale]  
1 Dichotomy 3 4-9 discrete ordinal categories 
2 Tricotomy 4 >9 discrete ordinal categories or 
continuous 
Source of data [Source]  
1 Self-report 4 Other (e.g., urinalysis) 
2 Other report (e.g., teacher, parent) 9 Cannot tell 
3 Official record (e.g., school, police, probation, court, institution) 
 
 Is this a valid or reasonable measure of recidivism?  
(1 = questionable; 2 = acceptable) 
[Valid]  
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12.2.5 Effect Size Level Code Sheet 
 
Identifying Information  
Study  identifier [StudyID]  
Module identifier  [ModID]  
Sample identifier [SampID]  
Outcome identifier [OutID]  
Effect size identifier (number each effect size within a study 
sequentially) 
[ESID]  
Coder’s Initials [CoderES]  
 
Effect size type 
Effect Size Information 
[ES_Type]  
1 Baseline (pretest; prior to start of intervention) 
2 Post-test (first measurement point, post intervention) 
3 Follow-up (all subsequent measurement points, post intervention) 
 
Which group does the raw effect (difference) favor (ignoring 
statistical significance)? 
[ES_Direc]  
1 Treatment group 
2 Comparison group 
3 Neither (ES equal zero) 
9 Cannot tell (ES cannot be used if this option is selected) 
 
Is this difference reported as statistically significant by the 
investigator? 
ES_Sig]  
0 No 8 Not tested 
1 yes 9 Cannot tell 
 
Time frame in months captured by measure (weeks/4.3) 
a Minimum [ES_Time1]  
b Maximum [ES_Time2]  
c Mean [ES_Time3]  
d Fixed (same for all subjects) [ES_Time4]  
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Does recidivism tracking period overlap with participation in drug 
court? 
[Es_PstTx]  
1 Completely 
2 Partially 
3 No overlap (recidivism is after participation ends) 
9 Can’t tell 
 
 
Effect Size Data 
Treatment group sample size for this effect size [ES_TxN]  
Comparison group sample size for this effect size [ES_CgN]  
 
Treatment group mean (clearly indicate decimal point) [ES_TxM]  
Comparison group mean  (clearly indicate decimal point) [ES_CgM]  
Are the above mean adjusted? (1=Yes; 0 = No)   [ES_MAdj]  
 
Treatment group standard deviation (clearly indicate decimal point) [ES_TxSD]  
Comparison group standard deviation  (clearly indicate decimal 
point) 
[ES_CgSD]  
Treatment group standard error (clearly indicate decimal point) [ES_TxSE]  
Comparison group standard error  (clearly indicate decimal point) [ES_CgSE]  
 
 
Treatment group; number successful [ES_TxNS]  
Comparison group; number successful [ES_CgNS]  
Treatment group; proportion successful [ES_TxPS]  
Comparison group; proportion successful [ES_CgPS]  
Are the above proportion adjusted for initial group nonequivalence? 
(1=Yes; 0 = No)   
[ES_PAdj]  
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t-value from an independent t-test or square root of F-value from a 
one-way analysis of variance with one df in the numerator (only two 
groups) 
[ES_T]  
 
Exact probability for a t-value from an independent t-test or square 
root of F-value from a one-way analysis of variance with one df in the 
numerator (only two groups) 
[ES_T_P]  
 
 
Chi-square value with df = 1 (2 by 2 contingency table)   [ES_ChiSQ]  
 
Correlation coefficient (point biserial) [ES_RPB]  
 
Correlation coefficient (phi) [ES_RPHI]  
Computer Calculated ES [ES]  
Hand Calculated ES [HAND_ES]  
Hand Calculated SE of ES [HAND_SE]  
 
 
 
 
 
 
 
 
 
